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Abstract: Bromine complexing agents (BCAs) are used to reduce the vapor pressure of bromine in the
aqueous electrolytes of bromine flow batteries. BCAs bind hazardous, volatile bromine by forming
a second, heavy liquid fused salt. The properties of BCAs in a strongly acidic bromine electrolyte
are largely unexplored. A total of 38 different quaternary ammonium halides are investigated ex
situ regarding their properties and applicability in bromine electrolytes as BCAs. The focus is on
the development of safe and performant HBr/Br2/H2O electrolytes with a theoretical capacity
of 180 Ah L−1 for hydrogen bromine redox flow batteries (H2/Br2-RFB). Stable liquid fused salts,
moderate bromine complexation, large conductivities and large redox potentials in the aqueous
phase of the electrolytes are investigated in order to determine the most applicable BCA for this kind
of electrolyte. A detailed study on the properties of BCA cations in these parameters is provided
for the first time, as well as for electrolyte mixtures at different states of charge of the electrolyte.
1-ethylpyridin-1-ium bromide [C2Py]Br is selected from 38 BCAs based on its properties as a BCA
that should be focused on for application in electrolytes for H2/Br2-RFB in the future.
Keywords: electrochemistry; bromine; quaternary ammonium salts; sequestration; hydrogen bromine
redox flow battery; electrolyte; liquid/liquid phase equilibrium
1. Introduction
Within the last ten years, numerous chemical combinations of negative and positive
half-cell chemistries for redox flow battery application have been published. The majority of
these compositions have been investigated on laboratory scale [1–3]. One commercialized
and noticeable redox flow battery system for stationary energy storage application is the
hydrogen bromine redox flow battery (H2/Br2-RFB) [4–6].
One of the challenges attributed to the H2/Br2-RFB application is the high vapor
pressure of bromine in the electrolyte solutions commonly used in this system [7]. In
this study, 38 cost-effective additives based on quaternary ammonium halide salts are
investigated for their applicability as bromine complexing additives (BCA) and their effects
on electrolyte properties. The most promising additive is selected for further investigation
in a cell. This systematic investigation is carried out for the first time for electrolytes in
H2/Br2-RFBs.
1.1. State of the Art
In this flow battery system, the negative half cell resembles the negative half cell
of a proton exchange membrane fuel cell anode, but is operated in a reversible mode.
Liquid posolytes based on hydrobromic acid (HBr), bromine (Br2) and water (H2O) are
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pumped through the positive half cell, while bromide (Br−) is oxidized to Br2 during
charge operation (Equation (1)) and vice versa during discharge operation [4,5,8]. In
some research articles, gaseous positive half cells operating with bromine vapor are also
discussed [4]. The thermodynamic cell voltage is 1.09 V [9]. Br2 itself is hardly soluble
in water [10–14]. Nevertheless, if bromide ions are present, Br2 forms polybromides
such as tribromide (Br3−), pentabromide (Br5−) or higher polybromides Br2n+1− [13,15,16]
following Equation (2):
2 Br− 
 Br2 + 2 e− (1)
Br− (aq) + n Br2 (aq) 
 Br2n+1− (aq) (2)
Bromine and bromide form addition bondings by complexation, resulting in the
previously mentioned polybromide cations Br2n+1− [17]. Complexation allows the main-
taining of high concentrations of Br2 in aqueous bromide solutions. These electrolytes are
particularly interesting for the application of Br2/Br− electrolytes in RFBs due to their
high theoretical energy density of up to 254 Wh L−1 and a theoretical volumetric capacity
of up to 233 Ah L−1 (HBr 48 wt%). Ideally, in order to achieve high power densities in
H2/Br2-RFBs, high concentrations of HBr and Br2 are indispensable [18]. Nevertheless, Br2
itself and in polybromide form is already quite volatile at ambient temperature [19–21] and
can react with different electrode and cell components of the H2/Br2-RFBs [4,22–26]. One
major concern is the crossover of Br2 from the positive to the negative half cell during cell
operation. When Br2 comes into contact with the platinum-based catalysts in the hydrogen
half cell, it can induce corrosive dissolution of platinum resulting in the formation of bro-
moplatinates [4,22–26]. The decay of the H2 electrode catalyst can be avoided by reducing
the concentration of Br2 in the positive half cell electrolyte.
Stabilization of polybromides by conversion into a less volatile form would reduce the
bromine vapor pressure, thus leading to a safer battery electrolyte [7]. Additives used to lower
bromine’s volatility have been applied in zinc bromine RFB (Zn/Br2-RFB) [8,27–39] and
vanadium bromine RFB (V/Br2-RFB) [40,41] electrolytes for a long time. These additives
are mostly based on organic quaternary ammonium cation compounds and are called
bromine complexing agents (BCA). Their bromide or chloride salts are usually highly
soluble in aqueous electrolytes. However, their polybromide salts are only slightly soluble
or even insoluble in aqueous media [33,36,42]. A further advantage of the polybromide
salts of quaternary ammonium BCAs is their low melting point, leading to an insoluble
ionic liquid at room temperature. In the electrolytes, these liquids form emulsions that
coalesce over time by forming a heavy second phase in the electrolyte [36], as shown in
Equation (3). For illustration, Figure 1 shows a photo of an electrolyte solution with a
two-phase liquid Br−/Br2/H2O/[BCA]+ electrolyte in the center.
[BCA]+ (aq) + Br2n+1− (aq) 
 [BCA]Br2n+1 (aq) 
 [BCA]Br2n+1 (fs) (3)
This heavy phase is often referred as the fused salt phase (fs), which sometimes tends
to crystallize [31,42]. In the past, many BCAs have been evaluated for their application on
zinc bromine batteries, out of which BCAs such as 1-ethyl-1-methylpyrrolidin-1-ium bromide
[MEP]Br and 1-ethyl-1-methylmorpholin-1-ium bromide [MEM]Br [8,27–34,38,39,42,43] have
received a lot of attention and have been investigated thoroughly. Other BCA structures
such as heteroaromatic BCAs based on alkylated pyridine, picolines or
imidazole [27,29,30,34,44], symmetrical and unsymmetrical alkylated aliphatic
BCAs [33,40,42] and alkylated cyclic cations [27,29,36,42] have also been reported in the
literature. Different side chains in N-position such as n-alkyl [27,29,31,33,34,36] or iso-alkyl
groups [31] have been used to investigate their steric influence on melting point, com-
plexation and solubility of the fused salt in Zn/Br2-electrolytes. 1-carboxymethyl [30],
hydroxyalkyl groups [27,29] and 1-chloromethyl groups [33,36,42] have been identified
to increase Br2 concentration in the aqueous phase in order to reduce precipitation of
[BCA]Br2n+1. Polar side chain groups of BCAs have been found to also increase the sol-
ubility of the BCA in aqueous solutions. Mixtures of BCAs have been chosen to overlap
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the positive properties of different BCAs and overcome the drawbacks of single BCA
properties [34,38,40–43].
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Figure 1. Scheme of the selection procedure of BCAs from 38 different compounds derived from six building blocks in
an aqueous HBr/Br2 electrolyte. The selecting process includes the properties of primarily the aqueous electrolyte phase,
such as safety, performance, stability, bromine sequestration and electrolytic conductivities. The results are used to draw
conclusions about the interaction of the [BCA]+ cations with the polybromides Br2n+1−, which are used to explain the
phenomena. On the basis of these results, one BCA out of 38 BCAs was selected for later investigations in the cell.
Comprehensive work on BCAs has been carried out for Zn/Br2-RFB electrolyte mix-
tures and the properties have been described by Cathro et al. [42], Eustace [36] and Lancry
et al. [31]. While the work on BCAs for Zn/Br2-RFB electrolytes is extensive and only a
few studies applying BCAs in V/Br2-RFB have been published so far, no systematic study
is available on the application of BCAs in HBr/Br2/H2O electrolytes for H2/Br2-RFB. In
addition, the influence of the different polybromides on the electrolyte properties has not
been investigated and is hardly documented in the literature for Zn/Br2-RFB [17].
1.2. Work Plan
In this work, we investigate 38 quaternary ammonium halides ex situ as prospective
BCAs for their suitability for application in Br−/Br2 electrolytes. The aim is to obtain
electrolytes for the positive half cell of a H2/Br2-RFB with a theoretical volumetric capacity
of 180 Ah L−1. All investigated BCAs are shown in Table 1. They comprise of substances
from six building blocks: (i) pyridines, (ii) pyrrolidines, (iii) morpholines, (iv) piperidines,
(v) 3-methylimidazoles and (vi) tetraalkylammonium compounds. In this research article,
the abbreviations listed in Table 1 are used for simplicity. In this study, the BCAs are
examined for solubility in the electrolyte, the stability of a secon liquid phase at room
temperature and their bro ine binding strength for a defined electrolyt composition.
BCAs that do not form a stable liquid seco d phase are either not soluble in the electrolyte
or show too low bromin binding strength and are exclud d from a detailed study as they
are not suitable for a battery application. BCAs, which are s ll of interest, are intensively
investigate over the entire state of charge (SoC) rang of the electrolyte ith a focus on
battery perfo mance-relevant parameters: stability, concentration of Br2 in the aqueous
elect olyte, redox potential as well a the elec roly ic conduct ity of the aqueous phase.
For th first time, detailed investigations r garding parameter development are carried out
on the basis of the measured distribu ion of Br2 on the polybromid s tribromide (Br3−),
pent bromide (Br5−) and heptabromide (Br7−) in the aq eous phase. Properties of the
fused salt phase are not discussed in detail here in order to retain the clarity of the article.
However, fused salt generally has low conductivity [36] and is therefore not the preferred
option for cell applications. The criteria are defined to select a BCA for the application; the
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observed phenomena are explained in detail, and lastly, one BCA is selected for further use
in a H2/Br2-RFB. The principle of this selection process is depicted in Figure 1.
Table 1. Quaternary ammonium halides for investigation of their properties as bromine complexing agents represented by
their structure, name and abbreviation (bold). Letters in brackets identify substances that are synthesized at Fraunhofer ICT
(S) and are used from commercial suppliers (C). Details are mentioned in the Supplementary Materials (SM).
Quaternary Ammonium Compounds Used as BCAs
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first time, detailed investiga ons regarding par met r d v lopment are carried out n the 
basi  of the m asured istribut on of Br2 o  the polybromides tribromide (Br3−), pentabro-
m de (Br5−) nd h ptabromide (Br7−) in the queo s phas . Proper ies of th f sed sal  
ph e re not di c ss in detail her  in der t  etain the clari y f th article. Howev , 
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cell p lica i s. Th  criteria r  fi d t selec  a BCA for the p lica ion; h  bser d 
ph nomena xplained in detail, d lastly, o e  is l c d for u th  use i a 
H2/Br -RFB. The principl  of this l ction pr ss i depicted in F gure 1.
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ICT (S) and re us d fro  co ercial sup liers (C). D tails re m nti ed i the Sup lem ntary Mater ls (SM). 
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first time, d tailed investigations regarding parameter dev lopment are c ied out on the 
basis of the m asured distr bu io  f Br2 on the polybromides tribromide (Br3−), pentabro-
mide (Br5−) and h ptabrom de (B 7−) in the queo s phas . Pr e ti s of th f s d salt 
pha e are not disc n e ail here in de  to r tain the clarity f the article. Howev r, 
fused salt ge r l y as low c n uctivi y [36] nd is therefore n t the pr f r d option for
cel  applic tio . The cr t a r  d fin d to s lec  a BCA for the pplica ion; he obs rv d 
ph nomen ar  xpl ined in etail, and lastly, o e BCA is sel ct d fo  u th  us  in a
H2/Br2-RFB. The prin ipl  of th s s lectio  pr c s  i  depict d in Figure 1. 
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first time, detailed investigations regarding parameter development are carried out n the 
basis of the measured distribution of Br2 on the polybromides tribromide (Br3−), pentabro-
mide (Br5−) and heptabromide (Br7−) in the aqueous phase. Properties of the fused salt 
phase are not iscussed in etail here in order to retain t e clarity of the article. However, 
fused salt generally has low conductivity [36] and is therefore n t the preferred option for 
cell applications. Th  criteria a  efined to selec  a BCA f r th  ap li tion; the observed 
phenom na re xplained in detail, an  lastly, one BCA is selecte  for furth r use in a 
H2/Br2-RFB. The rinciple of this selection proc ss is depicted in Figure 1. 
Table 1. Quaternary ammonium halides for inve tig ti n of their properties as bromin  compl xing ag nts presented 
by their structure, name and abbreviation (b ld). L tters in br ck ts d tify ubstances that a e synthesized at Fraunh fer 
ICT (S) and are used from commercial suppliers (C). Details are mentio ed in the Supplementary Materials (SM). 
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first time, d tailed investigations regarding par met r dev lopment are carried out on the 
basi  of the measured istribution f Br2 on the polybromides trib omide (Br3−), pentabro-
mide (Br5−) and heptabromide (Br7−) in the aqueo s phase. Properti s of the fused salt 
phase r  not discu sed in detail her  in order to retain the clarity of the article. Howev r, 
fused salt gen rally has low conductiv ty [36] and is ther fore not the pref rr d option for 
cell ap lications. The crite ia re d fined to sel ct a BCA for the ap lication; the observ d
phen mena re xplained in detail, and lastly, ne BCA is el ct d for fu ther use in a 
H2/Br2-RFB. The principle of this el ction process i  depict d in Figure 1.
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2. Results and Discussion 
2.1. Stabiltiy of Two-Phase Electrolytes and Bromine Binding Strength of BCAs 
A total of 38 BCAs are synthesized for this work (marked with “(S)” in Table 1) or 
ordered from commercial suppliers (marked with “(C)” in Table 1). The component struc-
ture of the synthesized BCAs is detected and confirmed by means of 1H NMR and 13C 
NMR. NMR results of all synthesized components are available in the SM (Section 2) and 
are verified on the basis of NMR results from the literature [45–51]. 
2.1.1. Solubility of [BCA]-Salts in Aqueous HBr Solutions 
For their application on the H2/Br2-RFB, the bromide or chloride salts of the BCAs 
(Table 1) need to be soluble in aqueous acidic electrolyte at room temperature. This be-
havior is studied by a simple solubility test. For all investigated BCAs, a solubility test in 
electrolyte solutions with 1.11 M [BCA]X (X = Br− or Cl−) and 5.47 M HBr in H2O is carried 
out at θ = 23 ± 1 °C. Most of the investigated substances are soluble in the electrolyte. 
Exceptions are the three BCAs [CTA]Br, [TOA]Br and [TOA]Cl. These compounds are not 
completely soluble in the mixture of HBr and H2O due to their long nonpolar alkyl side 
chains. Therefore, [CTA]Br, [TOA]Br and [TOA]Cl are not considered as BCAs for an ap-
plication in a battery and are not investigated further in this work. All the other BCAs of 
Table 1 are soluble bromide or chloride salts and are investigated on their bromine bind-
ing strength and solubility properties related to the addition of Br2. 
2.1.2. Stability of Two-Phase Electrolytes and Bromine Binding Strength of BCAs 
The soluble salts should form a liquid fused salt phase in a bromine electrolyte at 
room temperature, as crystallization of BCA salts in the pump or cell would lead to re-
duced volume rates and rising parasitic pressures. For the 35 soluble BCA salts, a com-
plexation test in electrolyte solutions by adding 1.11 M Br2 was performed. The total elec-
trolyte mixture corresponds to a mixture at an SoC of 33% (5.47 M HBr, 1.11 M Br2, 1.11. 
[BCA]X in H2O) at θ = 23 ± 1 °C. The SoC value is chosen, as it represents a 1:1 molar ratio 
of Br2 and BCA in the electrolyte. (A defintion of the SoC range is provided in the Materials 
and Methods section.) In the presence of aqueous polybromides, the BCA cations and the 
polybromides form either an orange-brown liquid fused salt phase or crystallize into red-
dish-brown or orange crystals. At the same time, a part of the Br2 remains in the aqueous 
electrolyte, resulting in a yellow to brown-colored aqueous electrolyte phase, depending 
on the applied BCA. The concentrations of Br2 in the aqueous solution and state of aggre-
gation of the second bromine-rich, heavy phase of all BCAs are shown in Figure 2. The 
results in the figure are sorted according to the decreasing Br2 concentration in the aque-
ous electrolyte solution, which reflects the increasing strength of the BCA to bind Br2 in 
the second phase. The bromine binding strength of the BCA is defined by the molar frac-
tion of Br2 stored in the fused salt phase compared to the total amount of Br2 in the sample. 
From left to right in Figure 2, the strength of the BCA in bromine binding increases. Ad-
ditionally, the solubility of [BCA]+ cations in the aqueous phase in the presence of polybro-
mides Br2n+1− decreases from left to right following Equation 3. Fused salts that crystallize 
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2. Results and Discu sion 
2.1  Stabilt y of Two-Phase El ctrolytes and Bromine Binding Strength of BCAs 
A to al of 38 BCAs are synthesized for this work (marked with “(S)” in Table 1) or 
orde ed from com ercial sup liers (marked with “(C)” in Table 1). The component struc-
ture of the synthesized BCAs is det cted and confirmed by means of 1H NMR and 13C 
NMR. NMR result  of all synthesized components are vailable in the SM (Section 2) and 
are verified on the basi  of NMR result  from the lit rature [45–51]. 
2.1  Solubility of [BCA]-Salts in Aqueo s HBr Solutions 
For their ap licat on the H2/Br2-RFB, the bromide or chloride salt  of the BCAs 
(Table 1) need to be solub e in aqueo s acid  el ctrolyte a  ro m temperature. This be-
havior s tudie  by a simple solubility test. For all investigated BCAs, a solubility test in 
el ctrolyte solutions with 1.  M [BCA]X (X = Br− o  Cl−) and 5.47 M HBr in H2O is carried 
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2. Results and Discussion
2.1. Stabiltiy of Two-Phase Electrolytes and Bromine Binding Strength of BCAs
A total of 38 BCAs are synthesized for this work (marked with “(S)” in Table 1)
or ordered fr m commercial suppli rs (ma ked th “ C)” in Table 1). The component
st uctu e of the synth sized BCAs is detect and confirmed by means of 1H NMR and
13C NMR. NMR r ult of all ynth sized compone ts a available in the SM (Section 2)
and are verified on the b sis of NMR results fr m the liter ture [45–51].
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2.1.1. Solubility of [BCA]-Salts in Aqueous HBr Solutions
For their application on the H2/Br2-RFB, the bromide or chloride salts of the BCAs
(Table 1) need to be soluble in aqueous acidic electrolyte at room temperature. This
behavior is studied by a simple solubility test. For all investigated BCAs, a solubility test in
electrolyte solutions with 1.11 M [BCA]X (X = Br− or Cl−) and 5.47 M HBr in H2O is carried
out at θ = 23 ± 1 ◦C. Most of the investigated substances are soluble in the electrolyte.
Exceptions are the three BCAs [CTA]Br, [TOA]Br and [TOA]Cl. These compounds are
not completely soluble in the mixture of HBr and H2O due to their long nonpolar alkyl
side chains. Therefore, [CTA]Br, [TOA]Br and [TOA]Cl are not considered as BCAs for an
application in a battery and are not investigated further in this work. All the other BCAs of
Table 1 are soluble bromide or chloride salts and are investigated on their bromine binding
strength and solubility properties related to the addition of Br2.
2.1.2. Stability of Two-Phase Electrolytes and Bromine Binding Strength of BCAs
The soluble salts should form a liquid fused salt phase in a bromine electrolyte at room
temperature, as crystallization of BCA salts in the pump or cell would lead to reduced
volume rates and rising parasitic pressures. For the 35 soluble BCA salts, a complexation
test in electrolyte solutions by adding 1.11 M Br2 was performed. The total electrolyte
mixture corresponds to a mixture at an SoC of 33% (5.47 M HBr, 1.11 M Br2, 1.11. [BCA]X
in H2O) at θ = 23 ± 1 ◦C. The SoC value is chosen, as it represents a 1:1 molar ratio of
Br2 and BCA in the electrolyte. (A defintion of the SoC range is provided in the Materials
and Methods section.) In the presence of aqueous polybromides, the BCA cations and
the polybromides form either an orange-brown liquid fused salt phase or crystallize into
reddish-brown or orange crystals. At the same time, a part of the Br2 remains in the
aqueous electrolyte, resulting in a yellow to brown-colored aqueous electrolyte phase,
depending on the applied BCA. The concentrations of Br2 in the aqueous solution and
state of aggregation of the second bromine-rich, heavy phase of all BCAs are shown in
Figure 2. The results in the figure are sorted according to the decreasing Br2 concentration
in the aqueous electrolyte solution, which reflects the increasing strength of the BCA to
bind Br2 in the second phase. The bromine binding strength of the BCA is defined by
the molar fraction of Br2 stored in the fused salt phase compared to the total amount
of Br2 in the sample. From left to right in Figure 2, the strength of the BCA in bromine
binding increases. Additionally, the solubility of [BCA]+ cations in the aqueous phase in
the presence of polybromides Br2n+1− decreases from left to right following Equation (3).
Fused salts that crystallize are shown as red bars, labelled by “S“, while stable liquid phases
at room temperature are shown as black bars.
Figure 2 allows an initial classification of the BCAs with regard to the stability of their
liquid fused salt phase and their binding strength towards Br2. The length of the alkyl
side chain in N-position of BCAs has a decisive influence on the solubility of the cation
in the presence of polybromide anions in the aqueous phase and on the stability of the
fused salt. As the length of the alkyl side chain increases, bromine concentrations in the
aqueous electrolyte phase (c(Br2(aq))) decrease, resulting in a rising binding strength of
the BCA versus Br2/polybromides in the fused salt. Already for n-propyl, n-butyl and
some BCAs with ethyl side chains in N-position, a concentration of c(Br2(aq)) < 0.1 M is
present in the aqueous phase, whereby more than 91 mol% of Br2 is transferred into the
fused salt. This increased binding of Br2 may increase the safety of the electrolyte, but it
also sustains less Br2 in the aqueous electrolyte. This can lead to mass transport limitations
during cell operation. Liquid fused salts with BCAs which are protonated in N-position
[HMP]+, [H4MPy]+, [H3MPy]+ and [HMPip]+ show a lower bromine binding strength
with Br2 concentrations between 0.22 to 0.33 M, which corresponds to a binding strength of
only 70 to 80 mol% versus Br2 in the fused salt. For the right choice of BCA, a compromise
between the safety due to strong Br2 binding property and the availability of polybromides
in the aqueous electrolyte at the electrode has to be made. The aqueous phase is essential
as it transports bromide, polybromides and protons, all required for the electrochemical
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reaction. The concentration values of Br2 in aqueous phases of the 35 samples are shown in
detail in Figure S1 in the SM.
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On the basis of our studies, we assume that the electron-donating inductive effect
(+I-effect) influences the observed trend in Figure 2. The +I-effect increases with rising alkyl
side chain length towards the nitrogen atom of the quaternary ammonium and leads to
higher bromine binding strength with longer alkyl side chain BCAs and lower [BCA]Br2n+1
solubility in the aqueous electrolyte. In detail, due to the +I-effect, the polarity of the
N atom is reduced, making the atom increasingly nonpolar and less soluble in the polar
HBr/H2O environment as the chain length is increased. In these cases, stronger interactions
with the polybromides might be given, while, due to reduced polarity, the interaction with
Br3−, Br5− and Br7− is preferred compared to polar Br− ions. To further explain the
differences in bromine complexation with increased chain length, in particular on N-
heterocycles, former studies on bromine interaction with quaternary ammonium ions can
be considered. Easton et al. [17], for example, have calculated the interaction of Br3− and
Br5− with different BCAs by DFT calculation and simultaneously determined the influence
of polybromides on the ydrogen atoms in the region arou d the nitrogen atom in the BCA
by 1H NMR spectroscopy. The protons in the α-positions of pyridinium, piperidinium and
pyrrolidinium rings interact most intensiv ly with the polybromide anion [17], which has
also been shown by Lungwitz et al. for the applicati n of polyiodines [52].
2.1.3. Influence of Bromide or Chloride Counter Ion of the BCA on Bromine
Binding Strength
Aqueous electrolytes containing BCAs with chloride counter ions have an increased
bromine bin ing strength compared to the same [BCA]+ cations with bromide counter
ions. They bind bromine 27.9 to 64.3% more strongly in the fused salt in comparison
to the equivalent [BCA]+ cation with bromide anions. Next to [C2MIm]Cl, all further
[BCA]Cl have a bromine binding strength of 93 mol% or higher, leading to a very low Br2
concentration in the aqueous electrolyte, which significantly limits their application in the
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RFB. Based on these results, this study concludes that chloride-based BCAs bind Br2 too
strongly, yet a detailed study on the reason for this observation is not within the scope of this
research article. It is only known in the literature that bromine forms with chloride mixed
polyhalides such as ClBr2− or ClBr4− [53–55], which may have different properties when
in contact with [BCA]+ cations. An evaluation of the differences between the complexation
of polybromides or polyhalides for these electrolytes requires a further study.
2.2. Crystallization Behavior of Fused Salt Phases
2.2.1. Influence of the Organic [BCA]+ Cation Structure on the Crystallization of Fused Salt
In order to understand the crystallization behavior of the various BCAs in the form of
their fused salts, the structure of the BCA main component and the length of the alkyl side
chain in N-position are considered. Crystallization of the fused salts of BCAs with N-hexyl
side chains does not occur for all tested BCAs, and in the case of n-butyl substituents it
occurs only sporadically. BCAs with an ethyl substituent ([C2MM]+) and 4-methylpyridin-
1-ium compounds tend to crystallize more frequently due to less steric hindrance and a
higher localized charge. Apart from [C2MIm]+, [C24MPy]+ and [C44MPy]+, the fused
salt of all heteroaromatic BCAs alkylated in the N-position remains liquid at SoC = 33%
and room temperature. The stability of their liquid phase at room temperature has also
been shown in the literature for Zn/Br2-RFB electrolytes, but based on different electrolyte
composition [27,29,30,34]. Reports on the precipitation of heteroaromatic BCAs could not
be found previously in the literature. The previously mentioned [C2MIm]+, [C24MPy]+
and [C44MPy]+, however, offer a pronounced symmetry and predominantly short alkyl
side chains. Protonated heteroaromatic BCAs ([HPy]Br, [HMIm]Br) without additional
alkyl groups at the aromatic ring also tend to crystallize, while [H4MPy]Br and [H3MPy]Br
form a liquid fused salt phase. A stable phase exists for [HMP]+ and [HMPip]+. Both of the
latter remain liquid, and all stable BCAs protonated in the N-position have comparatively
high Br2 concentrations between 0.2 M < c(Br2(aq)) < 0.35 M in the aqueous solution.
Their bromine binding strength is between 70 and 80 mol% (Figure 2). All examined
tetraalkylammonium bromides ([TEA]Br, [TBA]Br and [MTA]Br) are soluble in HBr/H2O
but crystallize with polybromides under the given conditions. The symmetry of the BCA
molecules leads to crystallization in H2/Br2-RFB electrolytes, which is also reported for
this group in Zn/Br2 electrolytes with a different electrolyte composition [42].
In conclusion, organic BCA cations with a high symmetry in structure and short alkyl
side chains tend to crystallize in contact with polybromides, while BCAs with long alkyl
side chains and/or an unsymmetrical BCA structure stay liquid when forming a fused salt
with polybromides.
2.2.2. Polybromide Species in [BCA]Br2n+1 Crystals
Beside the structure of BCAs, polybromides are found in the crystals. It raises the
question of whether individual polybromides have a decisive influence on the tendency to
crystallize with BCA cations. To investigate the reason behind the crystallization, Raman
spectra of dry crystals are studied and are shown in Figure S2 of the SM for most of the
[BCA]Br2n+1 crystals (except for [TBA]Br and [CTA]Br) and in Figure 3a using the example
of the BCA [C2MIm]Br.
The Raman spectra of all show the same distinct features: a very strong peak in
the Raman spectrum at a Raman shift (ṽ) between ṽ = 158–167 cm−1 and a weak peak
at ṽ = 180–200 cm−1, which is an adjacent shoulder of the strong peak. An example of
the Raman spectrum of [C2MIm]Br3 is shown in Figure 3a. Both peaks are characteris-
tic for tribromide ions Br3− due to its symmetrical (ṽ = 163 cm−1) and antisymmetrical
(ṽ = 198 cm−1) stretching vibration known from [56–58]. The absence of water’s characteris-
tic Raman bands, such as ṽ = 1600 cm−1 and between ṽ = 3000 cm−1 and 3800 cm−1 [59–62],
ensures that dry crystals have been studied. Peaks of higher polybromides Raman shifts
normally appear at ṽ = 210 cm−1 (Br5−, antisymmetric stretching vibration), ṽ = 253 cm−1
(Br5−, symmetric stretching vibration) and ṽ = 270 cm−1 (Br7−, symmetric stretching vibra-
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tion) according to Chen et al. [56] but are not detected during the investigation of crystals.
Higher polybromides, e.g., Br5− or Br7− are not present in the crystals.
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However, higher polybromides seem to be bound in the liquid fused salts. The spectra
of [C3MIm]Br2n+1, [C4MIm]Br2n+1 and [C6MIm]Br2n+1 are shown in Figure 3b, where the
presence of pentabromide and probably heptabromide is evidenced by the appearance of a
ak at ṽ = 255 cm−1. Figure 3b also shows an increase in peak intensity at ṽ = 160 cm−1
(Br3−) with increasing alkyl side chain length of the BCA, whereas the identified peak
at ṽ = 255 cm−1 (Br5−/Br7−) re ains constant. In general, the Raman peak hifts of the
crystal samples are similar to those of the fused salts [58]. With an increasing id chain
length at an SoC of 33%, bromine is preferentially added as Br3− ions. This me ns that
BCAs with longer side cha ns preferentially form a fused salt in which 3 acts as the
counter ion to he [BCA]+ cation, but does not crystallize due to steric hindrance from
t long alkyl side chain. On th othe hand, fused salts formed from BCAs with short
alkyl side chains are st ble liquid phases when, due to a mixture of Br3−, Br5− and Br7−,
the fraction of higher polybromide increases in comparison to Br3−. In this case, the
steric hindrance of the polybromides and charge distribution prevents the formation of
crystals. The distribution of Br2 in the polybromides depends o the BCA and the specific
interactions between BCA and the polybromides. Haller et al. [63] assume that higher
polybromides are less strongly bound by BCAs than lower polybromides or bromide ions.
In summary, symmetric and small BCAs tend to crystallize at room temperature with
Br3− ions because of their higher charge density and lower steric hindrance. Both long
side chains of heteroaromatic BCAs and large polybromides do not crystallize at room
temperature due to steric hindrance. An exception is [C2Py]Br, which also remains liquid
at room temperature.
For further consideration and application, therefore, N-alkylated pyridine-1-ium
compounds and 1-alkylated 3-methylimidazol-1-ium compounds are of particular interest.
With the alkyl side chains ethyl, n-propyl, n-butyl and n-hexyl, they all exhibit a bromine
binding strength of more than 80 mol% at an SoC of 33% resulting in a reduced vapor
pressure in the aqueous electrolyte solution. In order to compare their properties with well-
investigated BCAs such as [C2MP]Br and [C2MM]Br, these two BCA groups are included in
further experiments. In this first analysis, the focus has been set on the electrolyte mixture
of 1:1 ratio of Br2 to BCA at an SoC of 33%. However, electrolytes at an SoC of 33% only
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provide a selective insight into the electrolyte system of a flow battery. In the following,
the properties of the electrolytes are examined over the entire capacity range as a function
of the SoC.
2.2.3. Stability of Liquid Fused Salts within the Whole SoC Range
In the first preselection process, mainly heteroaromatic 1-alkylpyridin-1-ium and
1-alkyl-3-methylimidazole-1-ium bromides showed stable liquid fused salt phases at room
temperature. This has been investigated for a fixed electrolyte mixture of 1.11 M [BCA]Br,
5.47 M HBr and 1.11 M Br2. To operate the battery with electrolytes containing BCAs,
electrolyte stability over the entire SoC range between an SoC of 0% (7.6 M HBr, 1.11 M
[BCA]Br and H2O) and an SoC of 100% (1 M HBr; 1.11 M [BCA]Br, 3.35 M Br2 and H2O) is
required. Table 2 lists the investigated BCAs: [C2Py]Br, [C4Py]Br, [C6Py]Br, [C2MIm]Br,
[C3MIm]Br, [C4MIm]Br and [C6MIm]Br, as well as [C2MM]Br (known as [MEM]Br) and
[C2MP]Br (known as [MEP]Br), and indicates their usable SoC range for θ = 23 ± 1 ◦C.
For different mixtures, it is shown that all BCAs form a second phase over the entire
SoC range, except for an SoC of 0%. If Br2 is added to the aqueous solution, a separate fused
salt phase is formed immediately. For all 1-alkylpyridin-1-ium compounds investigated
for the entire SoC range, all fused salts remain liquid at room temperature over more
than three years. With the exception of [C2MIm]Br, all investigated 3-methyl-imidazolium
compounds form a liquid fused salt phase at room temperature within the entire SoC range.
Electrolyte samples with the aqueous and fused salt phase in the whole SoC range for
[C2MIm]Br, [C2Py]Br and [C6Py]Br are shown in Figure 4.
[C2MP]Br, [C2MM]Br and [C2MIm]Br form a solid crystalline phase with polybro-
mides in the lower SoC range (Table 2). With these three BCAs, a maximum of 40 to
70% of the capacity range (71.8 to 125.7 Ah L−1) can be used at room temperature, as a
crystallization of the fused salt cannot be accepted in the battery during operation. For
[C2MM]Br, [C2MP]Br and [C2MIm]Br, dry crystals of the second phase in the lower SoC
range are again examined by Raman spectroscopy. In the SoC range in which the fused
salts tend to form crystals, only tribromide Br3− salts of the BCAs are identified in addition
to the characteristic peaks for the respective organic cation (Table 2).
In previous studies, [C2MM]Br and [C2MP]Br have been applied in electrolytes for
Zn/Br2-RFB individually or in mixtures [8,28,30,33,38,41–43]. While the liquid fused salts
of the Zn/Br2 electrolytes are stable at room temperature, these BCA form crystals for the
selected acidic concentration at different SoC of a H2/Br2-RFB electrolyte. [C2MIm]Br,
[C2MM]Br and [C2MP]Br are therefore excluded for use at room temperature and lower
temperatures in H2/Br2-RFB since the formation of crystals in the cell or during operation
can lead to strong overpressure in the system. [C2MM]Br and [C2MP]Br as BCAs are not
investigated further in this study. On the other hand, [C2MIm]Br is reintroduced in the next
experiments in order to compare its properties to the other derivatives such as [C3MIm]Br,
[C4MIm]Br and [C6MIm]Br.
2.3. Bromine Binding Strength of [BCA]+(aq) Cations as a Function of the State of Charge (SoC)
The bromine binding strength of the individual BCAs has been determined based
on the concentration c(Br2) in the aqueous electrolyte solution compared to the total Br2
concentration at an SoC of 33% for the 35 chosen BCAs in Figure 5. Now, the change
of the [BCA]+ concentration over the SoC range will be considered to investigate its
effect towards the solubility and bromine binding properties for the seven BCAs based
on 1-alkyl-1-pyridin-1-ium bromides and the 1-alkyl-3-methylimidazol-1-ium bromides.
For the measurement of the BCA concentration in aqueous solution, the intensity of the
characteristic peaks with corresponding Raman shifts is investigated. The Raman shifts of
the [BCA]+ cations in aqueous solution are listed in Table 2. The Raman peaks selected for
the evaluation have certain Raman shifts, which are highlighted in Table 2 in bold. The
designated Raman shifts for the investigated BCAs are in agreement with the literature [64].
Concentrations of [BCA]+ cations in the aqueous phase are shown in Figure 5.
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Table 2. Selected BCAs to be investigated over the entire SoC range including the zone in which the second phase is present
as a liquid fused salt. Furthermore, characteristic Raman shifts of the [BCA]+ cation are shown, whereby the Raman peak
with the Raman shift in bold is used to determine the [BCA]+ concentration. In addition, the Raman shifts of the symmetrical
stretching vibration of the individual polybromides are shown, which are used for the evaluation in Section 2.5.
BCA Struc-
ture/Name/Abbreviation
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For different mixtures, it is shown that all BCAs form a second phase over the entire 
SoC range, except for an SoC of 0%. If Br2 is added to the aqueous solution, a separate 
fused salt phase is formed immediately. For all 1-alkylpyridin-1-ium compounds investi-
gated for the entire SoC range, all fused salts remain liquid at room temperature over 
more than three years. With the exception of [C2MIm]Br, all investigated 3-methyl-imid-
azolium compounds form a liquid fused salt phase at room temperature within the entire 
SoC range. Electrolyte samples with the aqueous and fused salt phase in the whole SoC 
range for [C2MIm]Br, [C2Py]Br and [C6Py]Br are shown in Figure 4. 
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range for [C2MIm]Br, [C2Py]Br and [C6Py]Br are shown in Figure 4. 
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range, the formation of a liquid fused salt phase occurs at room temperature. With increasing SoC, 
the volumes of the fused salt phase increase. In particular for the application of [C6Py]Br, the col-
oration of the aqueous phase from yellow to brown shows that the bromine concentrations in-
crease with increasing SoC. In addition, the SoC range is specified by total concentrations for an 
SoC of 0% and 100%. 
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measurement of the BCA concentration in aqueous solution, the intensity of the charac-
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Figure 4. Photos of electrolyte samples with different BCAs [C2MIm]Br, [C2Py]Br and [C6Py]Br as a function of SoC for an
SoC of 0, 10, 20, 30, 33, 40, 50, 60, 66, 70, 80, 90 and 100%. For electrolytes with [C2MIm]Br, between 0 < SoC < 60%, the
second electrolyte phase is shown to precipitate and to form crystals. For [C2MIm]Br at SoC ≥ 60%, [C2Py]Br, as well as
[C6Py]Br in the entire SoC range, the formation of a liquid fused salt phase occurs at room temperature. With increasing
SoC, the volumes of the fused salt phase increase. In particular for the application of [C6Py]Br, the coloration of the aqueous
phase from yellow to brown show that the bromi e concentrations increase with increasi g So . In addition, the SoC range
is specified by total conc ntrati n for an SoC of 0% and 100%.
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1-ium derivatives, the same trend is observed between 0 ≤ SoC ≤ 10% in Figure 5a.
Between 20 < SoC < 66%, the concentration of BCA continues to decrease for both groups
of substances, although these changes become smaller as the SoC increases. In this range,
the different bromine binding strength and solubility of the [BCA]+ cation with respect to
the polybromide species become visible. [C6Py]Br and [C6MIm]Br show a considerably
lower concentration in aqueous solution and therefore solubility as well as their property to
bind bromine more strongly, respectively, than that of BCAs with shorter alkyl side chains.
Organic cations of [C6Py]Br and [C6MIm]Br are no longer detectable in the solution even
at SoCs of 50% and 40%, respectively. [C4Py]Br, [C4MIm]Br and [C3MIm]Br follow this
trend at higher SoCs. [C2Py]Br and [C2MIm]Br show the lowest bromine binding strength
versus polybromides. Thus, higher concentrations of [C2Py]+ and [C2MIm]+ remain in
aqueous electrolytes at a higher SoC. From SoC ≥ 70% on, [C2Py]+ and [C2MIm]+ are not
detectable in the Raman spectrum. Experimentally determined detection limits for [BCA]+
cations in aqueous solution are listed in Table 3/line 1. Due to an increasing total Br2
concentration with an increasing SoC, the [BCA]+ cations are gradually transferred into the
fused salt phase. In principle, the SoC range can be divided into two sections: Depending
on the [BCA]+ cation, there is a section for lower SoC values where [BCA]+ cations are
present in the aqueous solution, and a section for higher SoC values, where [BCA]+ cations
are not present in the aqueous solution but are completely present in the fused salt phase.
Table 3. Detection limits and detection range for [BCA]+ in the aqueous electrolyte phase, maximum fractions of Br2 in the
aqueous phase compared to the global concentration and c(Br2)aq for an SoC of 33%.
[BCA]+ [C2Py]+ [C4Py]+ [C6Py]+ [C2MIm]+ [C3MIm]+ [C4MIm]+ [C6MIm]+
SoC limit for detectable
[BCA]+/% [a] ≤70 ≤66 ≤40 ≤60 ≤50 ≤40 ≤33
c(Br2)(aq)/c(Br2)total/% [b] ≤10.1 ≤10.3 ≤8.5 ≤10.4 ≤10.0 ≤10.6 ≤9.5
C(Br2)(aq) at an SoC of
30%/mM 121 51 9 105 63 34 8
[a] The SoC value corresponds to the highest SoC at which [BCA]+ cations can still be detected in the aqueous phase. [b] Highest ratio of
Br2 concentration in the aqueous phase versus the total Br2 concentration in the sample detected at an SoC of 90 or 100%.
The individual, BCA-dependent bromine binding strength is determined from the
[BCA]+ concentrations in the range of 20 ≤ SoC ≤ 60% and is applicable to investi-
gate the solubility behavior of the BCA. The BCAs can be sorted according to their
concentration in the aqueous phase. Low concentrations of [BCA]+(aq) in the aqueous
phase describe a larger bromine binding strength and vice versa. The bromine binding
strength is obtained in the following order: [C6MIm]+(aq) ≥ [C6Py]+(aq) > [C4MIm]+(aq) >
[C4Py]+(aq) > [C3MIm]+(aq) > [C2MIm]+(aq) > [C2Py]+(aq). Correspondingly, the solubil-
ity of [BCA]Br2n+1 in the aqueous electrolyte for the 1-alkylpyridine-1-ium polybromides
and for the 1-alkyl-3-methylimidazole-1-ium polybromides decreases with an increasing
length of the alkyl side chain. The detection limits of [BCA]+ cations in Table 3 show
that 1-alkyl-3-methylimidazol-1-ium is a slightly stronger bromine binding BCA than
1-alkylpyridin-1-ium if both have the same alkyl group in the N-position. As mentioned
earlier, the bromine binding strength cannot be the only criteria to choose a BCA. Moderate
Br2 concentrations in the aqueous phase along the whole SoC range are a prerequisite for
the operability of the cell and will be investigated in the next section.
2.4. Effect of the Solubility Equilibrium on the Br2(aq) Concentration for the Whole SoC Range
Br2 is transported from the tank into the RFB half cell as an ingredient of the aqueous
solution. Moderate Br2 concentrations dissolved as polybromide ions in the aqueous
electrolyte phase are a prerequisite for stable cell operation. The bromine concentrations in
the aqueous phase of the electrolytes for the investigated BCAs are plotted as a function of
the SoC in Figure 6.
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2.4.1. General Influence of BCA Application on Br2 Concentration in Aqueous Solution
Due to the relatively low solubility of the BCA-polybromide salt, the Br2 concentration
in the aqueous solution in equilibrium is low compared to the global concentration of
Br2 indicated by the absolute concentration in Figure 6. While the total concentration of
Br2 varies linearly along the SoC range, between c(Br2(total)) = 0.35 M at an SoC of 10%
and c(Br2(total)) = 3.35 M at an SoC of 100% (Figure 6), the solubility equilibrium of the
BCAs with the polybromides results in a significantly lower concentration of bromine
(c(Br2(aq)) < 0.35 M) in the entire SoC range for all investigated BCAs. In addition, no
linear relationship between c(Br2(aq)) and the SoC is observed. The maximum ratio of
Br2 in the aqueous phase compared to the total Br2 concentration is present for SoC > 80%
and is shown in Table 3/line 2. A maximum fraction of 11 mol% Br2 is present in the
aqueous solution, while a fraction of more than 89 mol% Br2 is present in the fused
salt phase. Although vapor pressures are not measured in this work, the safety of the
electrolytes increases tremendously due to the low Br2 concentrations and the resulting
reduced outgassing of Br2 from the aqueous electrolyte. Additionally, low concentrations
of c(Br2(aq)) would decrease the available bromine that can crossover across the membrane
to the H2 electrode inside the battery.
2.4.2. Individual Concentration Trends of Different [BCA]+ Cations
For BCAs based on 1-alkylpyridin-1-ium and 1-alkyl-3-methylimidazol-ium, charac-
teristic concentration curves for c(Br2(aq)) are obtained, whereby both diagrams in Figure 6
can be divided into two sections: In the first section (section I), between 0 < SoC ≤ 40% the
Br2 concentrations in the aqueous solution are different for each BCA but are approximately
independent of SoC and are also listed for an SoC of 30% in Table 3, on line 3. One exception
is the trend of [C2MIm]Br, which will be explained later. There is a clear trend in Br2 con-
centrations in the aqueous phase at an SoC of 30% for the applied BCAs, which corresponds
to the trend of BCA-concentrations in Section 2.3: c(Br2; [C6MIm]Br) < c(Br2; [C6Py]Br) <
c(Br2; [C4MIm]Br) < c(Br2; [C4Py]Br) < c(Br2; [C3MIm]Br) << c(Br2; [C2MIm]Br) < c(Br2;
[C2Py]Br). In this range, the bromine binding strength of the [BCA]+ cation is clearly visible
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again and corresponds exactly to the mentioned trends in Section 2.3: [C6MIm]+(aq) >
[C6Py]+(aq) > [C4MIm]+(aq) > [C4Py]+(aq) > [C3MIm]+(aq) > [C2MIm]+(aq) > [C2Py]+(aq).
The alkyl side chain length in the N-position in all BCAs is responsible for the differences in
complexing strength, which is just a handy indicator for the solubility of the [BCA]Br2n+1.
The longer the side chain, the lower the solubility of the [BCA]Br2n+1 in the aqueous solu-
tion. Another finding is that in general, the 1-alkyl-3-methylimidazol-1-ium compounds
are slightly stronger BCAs compared to the 1-alkylpyridin-1-ium, when the same alkyl
side chains are introduced. The concentrations of Br2 and [BCA]+ cations in the aqueous
solution both show the same trend.
For the Br2 concentrations of [C2MIm]Br between 10 ≤ SoC ≤ 50%, there is a con-
centration plateau in Figure 6b which differs from the c(Br2(aq)) curves for [C3MIm]Br,
[C4MIm]Br and [C6MIm]Br. As mentioned above, the second phase of [C2MIm]Br is
crystalline and consists solely of the tribromide compound ([C2MIm]Br3). Consequently,
the ratio of bromine to BCA cation is fixed to 1:1, and no higher polybromides can be stored
in the second heavy phase. This leads to rising Br2 concentrations in the aqueous phase
until the second phase liquefies again at SoC ≥ 50%, as presented in Figure 4.
The second section in Figure 6a,b starts from SoC > 40% (section II). Here the Br2
concentration increases noticeably for all BCAs, whereby the dependence of the Br2 con-
centration on the choice of the [BCA]+ cation decreases with increasing SoC. For both
1-alkylpyridin-1-ium and 1-alkyl-3-methylimidazolium cations as BCAs, the Br2 concentra-
tion for SoC ≥ 60% increases, whereby for each SoC value examined, approximately equal
concentrations c(Br2(aq)) are present in the aqueous solution. In this section, the length of
the alkyl side chain at the N-position of the BCA seems to have no influence on the binding
strength of Br2 of the second phase in solution. However, 1-alkylpyridin-1-ium bromides
bind bromine in section II slightly more strongly and tend to have a lower solubility in
the presence of polybromides at SoC > 60% as slightly lower Br2 concentrations in the
aqueous phase are present (Figure 6). In general, for SoC ≥ 80% the Br2 concentrations
rise only slowly or form a plateau. In that range, the solubility of Br2 in the aqueous
solution is limited by a lack of bromide ions to form polybromides, known from BCA-free
electrolytes [65].
It is noticeable over the whole range that for small amounts of Br2 at SoC ≤ 40%,
the complexation strength of the individual BCA types has a major influence on bromine
concentration in the aqueous phase, but at SoC ≥ 60% neither the type of BCA base nor the
length of the alkyl side chain seem to play a noticeable role, where all BCAs are considered
to complex polybromides to a similar extent. At the same time, there is a transfer of Br2
from the aqueous phase into the fused salt over the entire SoC range, but since it has been
shown above that no BCA cations are present in the aqueous solution at higher SoCs, the
transfer no longer occurs according to Equation (3).
2.4.3. Theoretical Comparison of Br2 Concentrations and Current Densities in the
H2/Br2-RFB Cell
Overall, the concentrations of c(Br2(aq)) are concentrations of Br2 in chemical equi-
librium for both phases and are only present during operation if the mass transfer of Br2
from the fused salt to the aqueous electrolyte phase takes place without any mass transfer
limitation, i.e., the equilibrium state is maintained during the discharge process. Applying
this theoretical assumption, the current densities of i = 723 mA cm−2 for c(Br2) = 0.3 M,
i = 482 mA cm−2 for c(Br2) = 0.2 M and i = 241 mA cm−2 for c(Br2) = 0.1 M would be possi-
ble in a cell with a geometrically active electrode/membrane area of 40 cm2 and a volume
flow rate of 30 mL min−1. Data for this cell are described in [65]. For electrolytes with
lower concentrations, the possible current densities would decrease further. Only [C2Py]Br
forms a liquid fused salt over the entire SoC range and has concentrations c(Br2) ≥ 0.121 M
in equilibrium between the two phases. In reality, lower concentrations can be expected in
the aqueous solution. Therefore, a current density i < 250 mA cm−2 for galvanostatic charg-
ing and discharging can also be expected for electrolytes with [C2Py]Br. As [H4MPy]Br,
[H3MPy]Br and [HMPip]Br upon first glance have aqueous Br2 concentrations between
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0.20 M and 0.35 M at an SoC of 33% in Figure 2, they seem to be more applicable for
effective cell operation. From Figure 6 it is noticed that in the range of an SoC of 33%,
Br2 concentrations in the aqueous solutions are lowest. For the protonated forms it is
therefore expected that for higher SoCs, much larger Br2 concentrations are present and
electrolytes cannot still be classified as “safe” electrolytes. From the results in this section,
it is expected that concentrations might rise for a higher SoC and lead to greater volatility
of Br2. [C2Py]Br tends to be the [BCA] of choice in order to reach performance and safety
of the Br2/Br− electrolytes.
2.5. Distribution of Br2 on Polybromides in the Aqueous Phase
As presented in the previous section, the aqueous Br2 concentration defines the power
capability of the cell. For a deeper understanding of the complexation behavior of the
different BCAs, the Raman spectra of the aqueous phase have been analyzed regarding the
distribution of bromine in the different polybromides. The method has been described in
our earlier work [65]. The distribution of Br2 on Br3−, Br5− and Br7− is shown in Figure 7.
The Raman spectra of all investigated samples are shown in the SM in Figures S3–S9.
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For an SoC of ≥ 40%, there is no dependence of the Br2 distribution in the aqueous 
phase on the length of the alkyl radical present in the N-position of the BCA. The distri-
bution is independent of the choice of the BCA basic compound pyridine or 3-methylim-
idazole. Within this SoC range, the fraction of Br2 stored as Br3- increases from 30.7% to 
41.6−47.3%, while proportionally less Br2 is stored in Br5− and the curve decreases from 
60% to 46–50%. Br2 remains in Br7− within the whole SoC range relatively constant up to a 
maximum of 13.5%. Presumably, a better solvation of the more stable Br3− compared to 
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polybromides are printed in the SM in Tables S3–S5.
An analysis of the distribution of Br2 among the polybromides Br3−, Br5− and Br7−
in the aqueous phase shows basically similar results for both BCA groups as shown in
Figure 7a,b. For all investigated BCAs, the storage of Br2 in the aqueous electrolyte in the
form of Br5− predominates, followed by storage in Br3− and finally storage in Br7−. This
is in accordance with earlier studies on pure BCA-free HBr/Br2/H2O-electrolytes [65],
leading to the result that [BCA]+ has only a minor influence on the fractions of Br2 in the
different p lybromide species in the aqueous soluti n. For SoC < 40%, the n-hexyl side
cha n BCAs [C6Py]Br and [C6MIm]Br have a slightly increased 2 content in Br3−, which
means tha less Br2 is distributed to the Br5− and Br7− a i ns. For SoC < 40%, n-butyl,
n-propyl and ethyl BCAs have a constant Br2 distribution, which is independent of the
BCA. For BCAs alkylated with an n-hexyl group, more Br3− is available, while less Br2
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is stored in Br5− and Br7−. In this range, cations of [C6Py]+ and [C6MIm]+ are available
in the aqueous solution and already prefer to interact with Br3− in comparison to Br5−
and Br7−. This is in accordance with the composition of their fused salt phases, shown in
Figure 3b.
For an SoC of ≥ 40%, there is no dependence of the Br2 distribution in the aque-
ous phase on the length of the alkyl radical present in the N-position of the BCA. The
distribution is independent of the choice of the BCA basic compound pyridine or 3-
methylimidazole. Within this SoC range, the fraction of Br2 stored as Br3− increases
from 30.7% to 41.6−47.3%, while proportionally less Br2 is stored in Br5− and the curve
decreases from 60% to 46–50%. Br2 remains in Br7− within the whole SoC range relatively
constant up to a maximum of 13.5%. Presumably, a better solvation of the more stable
Br3− compared to Br5− is present. This effect is obtained also for BCA-free HBr/Br2/Br−
solutions [65]. Since the Br2 concentration of c(Br2(aq)) < 0.35 M and the distribution of Br2
to the polybromides is relatively constant in the whole range, no specific influence of this
distribution on the performance or individual parameters is given and therefore cannot
be discussed.
2.6. Influence of Different BCAs on Electrolyte Conductivity of the Aqueous Phase
For both flow-by and flow-through electrodes in RFBs, a low ohmic cell resistance
is required to achieve high cell or stack performance. In RFB, this strongly depends on
the electrolyte composition at different SoCs, usually targeting the maximum electrolyte
conductivity of the aqueous electrolyte phase. Electrolyte conductivities of the aqueous
phases from the seven pre-selected [BCA]/Br2 electrolytes summarized in Table 2 are shown
in Figure 8. In addition, the reference conductivity curves of a BCA-free HBr/Br2/H2O
electrolyte (from [65]) and a pure HBr/H2O acid solution within the SoC range are shown
in Figure 8. All measured values are listed in Tables S6 and S7 in the SM. The values for
pure HBr/H2O acid at θ = 20 ◦C are calculated from molar conductivities from [66] and
are adapted to the SoC scale.
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Electrolytic conductivities in the aqueous phase depend mainly on the high proton
concentration and are larger than 300 mS cm−1 throughout the SoC range, whereby the
Grotthus mechanism [67,68] is responsible for ionic transport through the solution. In
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this chain-hopping mechanism, bonds are attached and released between water and pro-
tons in oxonium ions. Ionic transport by the vehicle mechanism [67] is subordinated to
the Grotthus mechanism in aqueous electrolyte solutions. With conductivities between
324.8 ≤ κ ≤ 745.0 mS cm−1, all aqueous electrolytes containing BCAs have large electrolyte
conductivities and are feasible for application in the H2/Br2-RFB.
The [BCA]+ cations in the electrolyte mixture influence the electrolyte conductivity
within the entire SoC range compared to BCA-free HBr/Br2/H2O electrolytes, as shown in
Figure 8. For 0 ≤ SoC ≤ 60% for both 1-alkylpyridin-1-ium electrolytes and for 1-alkyl-3-
methylimidazol-1-ium electrolytes, κ rises approximately from 368.90 to 478.00 mS cm−1
at an SoC of 0% to reach a peak at κ = 643.1−681.84 mS cm−1 between an SoC of 50 and
60%. Within this range, there is a difference from the two reference curves in accordance
with the concentrations of the [BCA]+ cation in solution, shown in Figure 5. Initially, the
organic character of [BCA]+ cation decreases the conductivity. Organic [BCA]+ cations
with longer alkyl side chains lead to lower conductivity in the aqueous phase due to their
increasing size. On the one hand, their migration in the electric field is slowed down and
the ionic transport by the Grotthus mechanism is restricted. Grotthus charge transfer on a
direct path between the electrodes is hindered and is forced to bypass the large organic
cations. However, as the SoC is increased, the conductivity of the aqueous electrolyte
in Figure 8 is shown to increase. This observation can be directly related to the results
presented in Figure 5, whereby the [BCA]+ concentration of the investigated BCAs in the
aqueous electrolyte is shown to decrease with the SoC as an indication that the cations are
now bonded to the fused salt phase and leaving the aqueous electrolyte phase. Thus, based
on these results, the decrease in the aqueous electrolyte [BCA]+ concentration translates
into the increased electrolyte conductivity trend seen in Figure 8 between 0 ≤ SoC ≤ 60%.
For electrolytes with 1-alkylpyridin-1-ium bromide as a BCA, the complexation
strength with respect to the side chain can be read in Figure 8a. Since [C6Py]+ with
polybromides Br2n+1− is less soluble in the aqueous phase than [C2Py]+, their concen-
tration decreases more rapidly compared to [C2Py]+. The conductivity of the solution
increases correspondingly more quickly in Figure 8a compared to electrolytes containing
[C4Py]+ or [C2Py]+.
In the second range for 60 < SoC ≤ 100%, there are hardly any [BCA]+ cations avail-
able in the aqueous phase, as presented in Section 2.3. In this range, no direct depen-
dence of conductivity on the alkyl side chain in the N-position of the [BCA]+ cation is
obtained. Electrolytes with BCAs show approximately same conductivities. With an in-
creasing SoC, the proton concentration decreases, and the conductivity of the solution
decreases subsequently.
However, electrolytes containing BCAs reach higher conductivities compared to BCA-
free HBr/Br2/H2O electrolytes for SoC ≥ 50% (green dots, in Figure 8). Due to the transfer
of Br2 by use of the BCA from the aqueous phase into the fused salt, only concentrations
lower than 0.35 M Br2 compared to the maximum total concentration of 2.99 M Br2 in
BCA-free HBr/Br2/H2O electrolyte (calculated from values in [65]) are present in aqueous
electrolytes. Since the absolute Br2 concentration in the aqueous electrolytes with BCA
is much lower, while the concentration of protons in both solutions is assumed to be the
same, the conductivity is higher when using BCAs and is comparable to pure HBr/H2O
solutions as shown in Figure 8. The Grotthus mechanism takes place directly between the
electrodes and does not need to bypass larger polybromides, as is the case in BCA-free
HBr/Br2/H2O electrolytes [65]. As for SoCs > 60%, the [BCA]+ cations are not available in
the aqueous phase; the conductivity of the resulting electrolytes in that range is shown to
be higher than in BCA-free HBr/Br2/H2O electrolytes.
Overall, in the complete SoC range there are conductivities between a minimum of
324.8 mS cm−1 (SoC 100%) and a maximum of 712.0−745.0 mS cm−1 (an SoC of 50%, depend-
ing on the [BCA]+), which are large in comparison to aqueous electrolytes of Zn/Br2-RFB using
the example of Eustace [36] with conductivities between 44.4 ≤ κ≤ 128.2 mS cm−1 (θ = 23 ◦C).
Pure aqueous solutions of comparable BCAs [C2MIm]Cl, [C4MIm]Cl and [C6MIm]Cl offer
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conductivities of κ≤ 82 mS cm−1 at θ = 25 ◦C [69], whereby a clear dependence on the alkyl
radical in the N-position of the 3-methylimidazole-1-ium can be confirmed from [69] with
κ([C2MIm]Cl(aq)) > κ([C4MIm]Cl(aq)) > κ([C6MIm]Cl(aq)).
In this work, the achieved conductivities correspond to those of a pure HBr/H2O
solution, which for an SoC of ≥ 60% means an increase in conductivity compared to
HBr/Br2/H2O electrolytes and has a positive effect on cell performance. These high conduc-
tivities are due to the presence of the high proton concentration of c(HBr) ≥ 1 M. The influ-
ence of BCAs is directly attributable to the presence of BCAs for an SoC
of < 60% and indirectly for an SoC of ≥ 60%. These high conductivities allow one to
obtain high current densities at a low expected electrolyte overvoltage, depending on the
half-cell structure.
2.7. Comparison of the Redox Potential of BCA-Free and BCA-Containing Electrolytes
To obtain a high-power density on an H2/Br2-RFB cell, a high thermodynamic cell
voltage is beneficial. The thermodynamic cell voltage of the H2/Br2-RFB is composed of
the difference of the half-cell redox potentials ϕ vs. NHE in open circuit state of the RFB.
The redox potential of the positive half-cell ϕ(Br2/Br−) depends, in the simplest scenario,
on the concentrations of the redox pair Br−/Br2 or Br−/Br2n+1− according to Nernst [70],
while assuming activity coefficients (γ) of γ = 1 for all components of the redox reaction
according to Equation (4):
ϕ(Br2|Br−) = ϕ0(Br2|Br−) - 0.5 R T F−1 ln(c(Br−)2 c(Br2) −1) (4)
In Equation (4), F is the Faraday constant (96485 As mol−1), R the molar gas constant
(8.3145 J mol−1 K−1) and T the temperature in K. ϕ0(Br2|Br−) is the standard redox
potential of the Br2/Br− electrolyte with 1.09 V [9]. The theoretical potential curve following
the Nernst equation (Equation (4)) and global concentrations of HBr and Br2 at T = 298.15 K
are applied. The curve is shown in Figure 9 as a function of the SoC (orange line). It has
much higher values at corresponding SoCs compared to the measured redox potential of
BCA-free electrolytes in Figure 9 (green dots). In the electrolyte system under investigation,
there are no ideally diluted solutions, but strongly concentrated electrolytes. As a result,
redox potentials according to the NERNST equation must be considered including activity
coefficients as shown in Equation (5) [70]:
ϕ(Br2|Br−) = ϕ0(Br2|Br−) − 0.5 R.T.F−1 ln(c(Br−)2 γ(Br−)2 c(Br2)−1 γ(Br2)−1) (5)
For low SoCs with high concentrations c(HBr) > 1.2 M of HBr, the activity coefficients
for γ(HBr) > 1 are available (calculated with data from [71]). Increasingly higher activities
a(HBr) = c(HBr) γ(HBr) must be taken into account in the calculation of the redox potential
of the positive half cell due to constantly increasing activity coefficients of HBr in the
aqueous solution [71]. Wlodarczyk et al. [70] clearly show that the increasing activity
coefficients of HBr for low SoCs leads to a strong decrease in the redox potential of the
bromine electrolyte at an electrode according to Nernst compared to a pure concentration-
based calculation.
The measured redox potential ϕ(Br2/Br−) of the pure HBr/Br2/H2O electrolytes
(green curve in Figure 9) increases with an increasing SoC from 0.76 V vs. NHE (at an
SoC of 0%) and a maximum value at an SoC of 100% at 1.12 V vs. NHE. For SoC ≥ 89.4%,
Br2 is not completely soluble in the aqueous solution as explained in [65]. The aqueous
solutions contain less Br2, and the redox potential flattens following the Nernst equation
(Equation (5)).
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In principle, the redox potential of the aqueous electrolyte solution with the use
of [BCA]Br in the presence of Br2 is lower within the entire SoC range compared to
BCA-free HBr/Br2/H2O electrolytes (Figure 9). The transfer of Br2 into the fused salt
reduces the bromine concentration in the aqueous solution, while at the same time the HBr
concentrations stay nearly constant in comparison to BCA-free HBr/Br2/H2O electrolytes.
Hence, according to Equation (4), the redox potential of [BCA]Br electrolytes is slightly
lower when compared to the BCA-free HBr/Br2/H2O electrolytes. For SoCs < 50%, the
solubility of the respective [BCA]+ cation is responsible for the trend observed in Figure 9.
In accordance with lower bromine concentrations in the electrolyte for increasing the n-alkyl
side chain length (Figure 6), lower redox potentials are observed with the BCA electrolytes
with larger n-alkyl chain. For SoCs > 50%, the difference between the potentials of the
pure HBr/Br2/H2O electrolyte and the electrolytes containing BCA becomes increasingly
larger. In global terms, the Br2 concentration increases strongly, which can be seen in the
potential of the BCA-free HBr/Br2/H2O electrolyte, but at the same time the majority of
the Br2 in the solutions with BCAs is transferred to the fused salt. The redox potentials of
the electrolytes with BCAs increase at a slower rate with an increasing SoC.
The use of [BCA]Br leads to an average reduction in the redox potential of the positive
half cell and the cell voltage ∆E by 32 ≤ ∆E ≤ 114 mV for all BCAs and over the entire SoC
range compared to pure HBr/Br2/H2O electrolytes. The performance of the cell is reduced
by this effect, while it is already lowered by high activity coefficients of HBr [70,71]. Fabjan
et al. [8] described for Zn/Br2-RFB electrolytes that solutions of [C2MM]Br and [C2MP]Br
reduce the concentration of Br2 in the aqueous phase to approximately 0.01 M, and the
redox potential is characteristically reduced by 50 to 70 mV. This applies to our electrolytes
and both BCA series in Figure 9 for the range 30 ≤ SoC ≤ 70%. A lower cell voltage due to
the use of BCAs must be accepted as a trade-off for limiting the Br2 concentration in the
aqueous solution.
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2.8. Interpretation of the Study and Selection of a Promising BCA for Application in Cell Tests
In the scope of this research, 38 cost-effective BCAs have been investigated and evalu-
ated on the basis of their solubility, Br2 binding strength, ionic conductivity and equilibrium
potential for their possible application as electrolytes on H2/Br2-RFBs. In the following,
an elimination procedure is applied to select the most suitable BCA for battery operation.
The BCAs are excluded on the basis of the results obtained in the previous sections. To
start, based on their solubility, [CTA]Br, [TOA]Cl and [TOA]Br do not dissolve in a polar
HBr/H2O solution due to their long nonpolar alkyl groups. In addition, other BCAs such as
[HPy]Br, [TEA]Br, [C2MPip]Br, [C2MP]Br, [C2MM]Br, [C4MM]Br, [HMIm]Br, [C2MIm]Br,
[MTA]Br, [TBA]Br, [C24MPy]Br and [C44MPy]Br form solid crystals in the aqueous solu-
tion instead of a liquid fused salt when they come into contact with polybromides. Hence,
none of these BCAs can be used in the cell as the spontaneous formation of crystals in the
cell, tubing and pumps can lead to operational problems.
Since the H2/Br2 RFB is intended to be operated at high current densities due to the
good reaction kinetics of both electrode reactions, a high mass flow of Br2 into the cell
during the discharge reaction is necessary, making high concentrations of Br2 desirable.
At the same time, it is the task of the BCAs to reduce the bromine concentration in the
aqueous phase in order to increase safety. All BCAs that form a liquid fused salt phase and
have long alkyl side chains such as n-butyl or n-hexyl have a bromine binding strength
of >95 mol%. Additionally, all BCAs with a liquid fused salt phase and ethyl or n-propyl as
a side chain, with the exception of [C2Py]Br, have a bromine binding strength of >90 mol%.
These BCAs do not leave sufficient Br2 in the aqueous phase of the electrolyte to achieve
acceptable current densities. [HMP]Br, [H4MPy]Br, [H3MPy]Br and [HMPip]Br show only
a bromine binding strength of 70 to 80 mol% at an SoC of 33% with concentrations between
0.22 to 0.33 M, while it is expected that for higher SoC values, larger Br2 concentrations
than 0.5 M are available. The essential safety might not be achieved at these concentrations.
It is therefore proposed to investigate 1-ethylpyidin-1-ium bromide [C2Py]Br as BCA
in further studies in the RFB cell. From the seven BCAs investigated over the entire SoC
range, [C2Py]Br exhibits the most advantages. Even though there is a reduction in the
electrolyte conductivity and the redox potential when compared to the BCA-free one,
the concentrations of Br2 in the aqueous solution are higher compared to solutions with
[C4Py]Br and [C6Py]Br. In the [C2Py]Br, electrolytes at least 89 mol% Br2 remain in the
fused salt phase, yet the electrolytes still maintain large Br2 concentrations, between 0.12 M
to 0.26 M, in the aqueous solution. The availability of Br2 in the liquid electrolyte phase
turned out to be a decisive factor in our selection, making this compound clearly stand
out over all the other investigated BCAs. The initial cycling tests and investigation of the
[C2Py]+ cations on the cell performance during the charge and discharge operation are
shown in parallel in [72].
3. Materials and Methods
A detailed description of the testing methods is given in the SM (Section 1) for this arti-
cle to enable reproducibility of the measurements. An abbreviated form is reproduced here.
3.1. Reagents
Reagents used for preparation of bromine electrolyte samples in this work are hydro-
bromic acid, bromine and distilled water. Chemicals for the synthesis of BCAs are named
in the Supplementary Materials (SM) including suppliers and purities.
3.2. Synthesis of Bromine Complexing Agents
The investigated BCAs are listed in Table 1, including chemical structure, name and ab-
breviation. Non-commercially available N-alkylated quaternary ammonium bromide salts
based on pyridine ([C2Py]Br, [C4Py]Br, [C6Py]Br, [C6Py]Cl), on 3-picoline ([C23MPy]Br,
[C43MPy]Br, [C63MPy]Br), on 4-picoline ([C24MPy]Br, [C44MPy]Br, [C64MPy]Br), on
1-methylimidazole ([C2MIm]Br, [C3MIm]Br, [C4MIm]Br, [C6MIm]Br, [C6MIm]Cl), on 1-
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methylpiperidine ([C2MPip]Br, [C4MPip]Br, [C6MPip]Br,) and on 1-methylpyrrolidine
([C6MP]Br) are synthesized by alkylation reaction [45,73] according to Dzyuba et al. [74].
Some BCAs are available as golden liquids at reaction temperatures between 40 ◦C and
100 ◦C, while some precipitate as golden or white solids. 1H NMR and 13C NMR spectra of
the synthesized substances are presented in SM and are consistent with NMR shifts found
in the literature [45–49]. Protonated forms of 4-picoline, 3-picoline, 1-methylpiperidine,
pyridine, 1-methylimidazole and 1-methylpyrrolidine ([H4MPy]Br, [H3MPy]Br, [HMP]Br,
[HMPip]Br, [HPy]Br, [HMIm]Br) are prepared by dissolving the heterocyclic ammonium
compound with a calculated excess of HBr in the electrolyte solution.
3.3. Electrolyte Formulation
For each BCA, a sample of 10 mL is mixed in aqueous solution containing 5.47 M HBr,
1.11 M [BCA]Br or [BCA]Cl. HBr 48 wt% and H2O are added volumetrically. Solubility
of [BCA]Br or [BCA]Cl is evaluated. To solutions, in which the BCA salt is dissolved, Br2
with a mass of 1.77 g (1.11 M Br2) is added gravimetrically. All mixtures correspond to an
electrolyte mixture for an SoC of 33%.
For selected BCAs [C2MM]Br, [C2MP]Br, [C2Py]Br, [C4Py]Br, [C6Py]Br, [C2MIm]Br,
[C3MIm]Br, [C4MIm]Br and [C6MIm]Br, electrolyte properties are investigated ex situ
within the entire SoC range. The SoC range is defined for SoC 0% with 7.7 M HBr, 1.11 M
[BCA]Br and 0 M Br2 and for an SoC of 100% with 1 M HBr, 1.11 M [BCA]Br and 3.35 M Br2.
The SoC definition is derived from another study [65]. Samples with a volume of 30 mL in
a test series with SoC steps of 10%, and additionally for an SoC of 33% and 66%, are mixed.
3.4. Stability of Fused Salt Electrolyte
The stability of the fused salt is checked by visual inspection. The criteria for qualifica-
tion of the liquid range of a fused salt are the absence of visible orange or red crystals in
the fused salt.
3.5. Concentration of [BCA]+ Cations in Aqueous Electrolytes
Concentrations of 1-alkylpyridin-1-ium cations and 1-alkyl-3-methylimidazol-1-ium
cations in the aqueous electrolyte phase are determined by Raman spectroscopy over the
entire SoC range. Both cations show characteristic strong peaks at distinctive Raman shifts
especially due to their aromaticity [64,75,76]. Characteristic Raman shifts of peaks of the
BCAs are shown in Table 2. Peak areas at this Raman shifts are determined and compared
with peak areas at known [BCA]+ concentrations (an SoC of 0% and 1.11 M [BCA]Br).
[BCA]+(aq) concentrations as a function of the SoC are therefore calculated (ESI).
3.6. Br2 Concentration in Aqueous Electrolyte Phase
Br2 binding strength of the BCA or solubility of the [BCA]Br2n+1 complex is investi-
gated by measurement of Br2 concentration in aqueous electrolyte phase. Concentrations of
Br2 are investigated by linear chronoamperometry at a rotating disk electrode. At a rotation
speed of ω = 1000 rpm on vitreous carbon electrode, linear sweep scans between 0.8 V and
−0.5 V vs. an Ag/AgCl/KCl(sat.) reference electrode and a scan rate of –40 mV s−1 are per-
formed for all samples. Constant reduction currents result for half-cell potentials < −0.1 V
vs. Ag/AgCl/KCl(sat.), which represent mass transport limitation by Br2 from the bulk
phase [77,78]. According to Levich [77–80], reduction currents are directly proportional
to the c(Br2) of the bulk solution. Concentrations c(Br2(aq)) in M are calculated from the
limiting currents Ilim (in mA) shown in Equation (6):
c(Br2(aq)) = 0.00342466 mol L−1 mA−1 Ilim (6)
A linear calibration curve with known bromine concentrations is investigated before
at same conditions. Br2 concentrations are measured for the aqueous electrolyte phase
of 35 samples with different BCAs chosen at an SoC of 33% and the series of electrolyte
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samples with [C2Py]Br, [C4Py]Br, [C6Py]Br, [C2MIm]Br, [C3MIm]Br, [C4MIm]Br and
[C6MIm]Br at 13 different SoCs.
3.7. Polybromide Determination, Polybromide Distribution and [BCA]+ Concentration
Determination by Raman Analysis
By means of Raman spectroscopy on the aqueous electrolyte samples, second phase
crystals and fused salt samples, the occurrence of the different polybromides tribromide
Br3−, pentabromide Br5− and heptabromide Br7− in electrolyte series of 1-alkylpyridin-1-
ium cations und 1-alkyl-3-methylimidazol-1-ium cations electrolytes at different SoCs were
investigated. Raman shifts for polybromides and bromine were determined between ṽ = 150
and 320 cm−1 as described in the literature [17,56,81,82]. Peak areas of the following stretching
oscillations of the polybromides were determined: ṽ(Br3−, sym.) = 162–163 cm−1 [17,53,56],
ṽ(Br3−, antisym.) = 190–198 cm−1 [17,56,83], ṽ(Br5−, antisym.) = 210 cm−1 [17,56], ṽ(Br5−,
sym.) = 250–253 cm−1 [17,56,81,83,84], ṽ(Br7−, sym.) = 270 cm−1 [56,81]. In the literature,
pure Br2 shows a strong, single peak at ṽ(Br2, sym.) = 300–325 cm−1 [81,83,84]. Since there
are differences in Raman shifts between the aqueous solution and the corresponding fused
salt phase, Raman shifts actually used for fitting the individual peaks are shown in Table 2
for the investigation of the aqueous electrolyte phase. Investigation of Br2 distribution in
polybromides is explained in detail in the SM and literature [65].
3.8. Electrolytic Conductivities of Aqueous Phase
Electrolytic conductivities of the aqueous electrolytes of 1-alkylpyridin-1-ium BCAs
and 1-alkyl-3-methylimidazol-1-ium BCAs electrolyte at various SoC are determined at
θ = 23 ± 1 ◦C in a conductivity cell by potentiostatic impedance spectroscopy. The cell
constant is determined in a 1 M KCl aqueous solution at θ = 23 ± 1 ◦C with κ (1 M KCl at
θ = 23 ◦C) = 103.9 mS cm−1 (calculated from [85]). A detailed description can be found in
the ESI.
3.9. Redox Potential of the Electrolytes
The redox potentials of the aqueous electrolyte solution are investigated on a glassy
carbon stick electrode vs. an Ag/AgCl/KCl(sat.) reference electrode at θ = 23 ± 1 ◦C and
corrected to present them vs. a normal hydrogen electrode. A detailed description can be
found in the ESI.
4. Conclusions
In this study, tertiary ammonium compounds of pyridine, pyrrolidine, morpholine,
3-methylimidazole, tetraalkylammonium and picolines have been alkylated with n-alkyl
side chains in the N-position to form organic bromide or chloride salts. In combination
with some commercially available organic salts, this resulted in 38 organic quaternary
ammonium substances from these six N-containing building blocks. The substances
have been investigated ex situ on their properties as BCAs in HBr/Br2-electrolytes: BCA
solubility, Br2 binding strength, the stability of the second heavy fused salt phase, Br2
concentration for application, electrolyte conductivity and redox potential. This study has
been performed to define their applicability of BCAs to limit the vapor pressure of Br2 in
aqueous highly concentrated electrolytes for a high-energy density H2/Br2-RFB with a
theoretical capacity of 180 Ah L−1/196 Wh L−1 (7.7 M HBr).
From the 38 substances evaluated, 15 are not soluble in the electrolyte or form a
crystal phase in contact with polybromides. This behavior makes them unsuitable for
their application in RFBs. We found that BCAs with short side chains and/or symmetric
structure tend to form crystals instead of forming liquid fused salts. An investigation of
the [BCA]-polybromide crystal composition showed that all BCA crystals are tribromide
salts [BCA]Br3.
All the other BCAs form fused salt phases, while most of them exhibit a strong bromine
binding strength (14 substances > 95 mol% and four substances between 90 to 95 mol%);
four of the N-position protonated BCAs show insufficient binding strengths (<80 mol%).
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The binding strength increases with an increase in alkyl side chain length, yet the structure
of the six basic components (pyridine, picoline, etc.) only has minor influence on the
bromine binding strength in solutions.
1-alkyl-3-methylimidazol-1-ium and 1-alkylpyridin-1-ium bromides have been inves-
tigated within the whole SoC range to compare the influence of side chain alkyl groups on
the different parameters evaluated throughout this study:
For a low SoC (<40%), the selected BCAs show different bromine binding strengths. A
clear trend has been found as short alkyl side chains lead to lower Br2 binding strength
compared to those with long alkyl side chains. For an SoC of ≥40%, the concentrations
of Br2 in the electrolyte’s aqueous phase increase, while the binding strength becomes
independent of the alkylated side chain. However, to obtain a clear insight on the reason
behind this behavior, further investigation on the fused salt phase would be needed which
is beyond the scope of this study. On a final note regarding this comparison, it is worth
mentioning that the ability to form a fused salt phase differed from that of the [C2Py]Br
and the [C2MIm]Br BCAs as we observed that while [C2Py]Br forms a liquid fused salt,
the cation of [C2MIm]Br tends to crystallize over a wide SoC range.
The ionic conductivity of the aqueous phase is high for the whole SoC range be-
tween 325 and 745 mS cm−1 and depends primarily on the available proton concentration
and its ionic transport by the Grotthus mechanism. The concentration of [BCA]+ in the
aqueous phase can, to a lesser extent, influence the measured ionic conductivities of the
electrolytes as their presence can slightly reduce the conductivity or increase it indirectly
by sequestration of Br2 from the aqueous phase.
The redox potential of the electrolyte is reduced by 32 to 114 mV due to the use of
BCAs compared to BCA-free electrolytes in the whole SoC range. Following the Nernst
equation, the decrease in Br2 concentration in the aqueous phase leads to reduced redox
potentials of the half-cell reaction. This is certainly a trade-off that must be accepted as it
is a direct consequence of the ambition to lower bromine vapor pressure by limiting Br2
concentration in aqueous solutions.
Based on the results of fused salt stability over the SOC range, electrolyte conductivity,
the trend of the redox potential and especially the concentrations of Br2 remaining in the
aqueous electrolyte phase, one BCA was selected from 38 BCAs and needs to be investigated
in detail and applied in the positive half cell of the H2/Br2-RFB cell: 1-ethylpyridin-1-ium
bromide ([C2Py]Br).
Supplementary Materials: The following are available online: Detailed description of the mea-
surement methods, synthesis of BCAs, manufacturers’ data and chemical purities (Chapter S1), as
well as 1H NMR and 13C NMR interpretation for synthesized BCAs (Chapter S2), tabulation of
measured values for Figures within the main manuscript (Table S1–S8), Raman spectra of solutions
(Figures S3–S9), Raman spectra of [BCA]Br3 crystals (Figure S2) and concentrations of Br2 in aqueous
solution for all 35 BCAs investigated (Figure S1).
Author Contributions: Conceptualization, M.K.; methodology, M.K.; synthesis, E.M. and P.A.L.T.;
validation, M.K.; formal analysis, M.K., P.A.L.T. and P.F.; investigation, M.K., P.A.L.T. and E.M.;
resources, P.F., J.T. and M.K.; data curation, M.K. and P.A.L.T.; writing—original draft preparation,
M.K.; writing—review and editing, M.K., P.A.L.T., P.F. and J.T.; visualization, M.K.; supervision, M.K.
and P.F.; project administration, M.K.; funding acquisition, M.K., P.F. and J.T. All authors have read
and agreed to the published version of the manuscript.
Funding: The authors thank the Federal Ministry of Education and Research (BMBF) in the project
“PEDUSA” (03XP0135) and the State of Baden-Wuerttemberg/Germany in the project “RedoxWind”
for the funding.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: Data is contained within the article or supplementary material.
Molecules 2021, 26, 2721 24 of 26
Acknowledgments: The authors would like to thank Michael Holzapfel (Fraunhofer ICT) for the
preliminary discussion of experiments.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Noack, J.; Roznyatovskaya, N.; Herr, T.; Fischer, P. The Chemistry of Redox-Flow Batteries. Angew. Chem. Int. Ed. 2015, 54,
9776–9809. [CrossRef]
2. Ponce de León, C.; Frías-Ferrer, A.; González-García, J.; Szánto, D.A.; Walsh, F.C. Redox flow cells for energy conversion. J. Power
Sources 2006, 160, 716–732. [CrossRef]
3. Weber, A.Z.; Mench, M.M.; Meyers, J.P.; Ross, P.N.; Gostick, J.T.; Liu, Q. Redox flow batteries: A review. J. Appl. Electrochem. 2011,
41, 1137–1164. [CrossRef]
4. Cho, K.T.; Tucker, M.C.; Weber, A.Z. A Review of Hydrogen/Halogen Flow Cells. Energy Technol. 2016, 4, 655–678. [CrossRef]
5. Tolmachev, Y.V. Hydrogen-halogen electrochemical cells: A review of applications and technologies. Russ. J. Electrochem. 2014, 50,
301–316. [CrossRef]
6. Hugo, Y.A.; Kout, W.; Dalessi, G.; Forner-Cuenca, A.; Borneman, Z.; Nijmeijer, K. Techno-Economic Analysis of a Kilo-Watt Scale
Hydrogen-Bromine Flow Battery System for Sustainable Energy Storage. Processes 2020, 8, 1492. [CrossRef]
7. Bajpai, S.N. Vapor pressures of bromine-quaternary ammonium salt complexes for zinc-bromine battery applications. J. Chem.
Eng. Data 1981, 26, 2–4. [CrossRef]
8. Fabjan, C.; Hirss, G. Über die Kinetik und den Mechanismus der Brom/Bromid-Redoxelektrode: Grundlagen von Elektroden-
reaktionen. Dechema Monogr. Band 1985, 102, 149–161.
9. Bard, A.J.; Parsons, R.; Jordan, J. Standard Potentials in Aqueous Solution: Bromine; CRC Press: New York, NY, USA, 1985;
ISBN 978-0824772918.
10. Seidell, A. Solubilities of Inorganic and Organic Compounds; D. Van Nostrand Company: New York, NY, USA, 1919.
11. Bray, W.C. The hydrolysis of iodine and bromine. J. Am. Chem. Soc. 1910, 32, 932–938. [CrossRef]
12. Worley, F.P. CXVII.—Bromine in solutions of potassium bromide. J. Chem. Soc. Trans. 1905, 87, 1107–1123. [CrossRef]
13. Jones, G.; Baeckström, S. The Standard Potential of the Bromine Electrode. J. Am. Chem. Soc. 1934, 56, 1524–1528. [CrossRef]
14. Benizri, R.; Lessart, P.; Courvoisier, P. Etude de l’equilibre de Etude de l’equilibre de phases liquides-gaz dans le systeme
bromeacide bromhydrique-eau. Hydrog. Energy Vector 1980, 1, 101–116. [CrossRef]
15. Griffith, R.O.; McKeown, A.; Winn, A.G. The bromine-bromide-tribromide equilibrium. Trans. Faraday Soc. 1932, 28, 101–107.
[CrossRef]
16. Scaife, D.B.; Tyrrell, H.J.V. Equilibrium constants for the reaction between bromine and bromide ions at 5◦, 25◦, and 35◦ in
aqueous medium of constant ionic strength and acidity. J. Chem. Soc. 1958, 0, 386–392. [CrossRef]
17. Easton, M.E.; Ward, A.J.; Chan, B.; Radom, L.; Masters, A.F.; Maschmeyer, T. Factors influencing the formation of polybromide
monoanions in solutions of ionic liquid bromide salts. Phys. Chem. Chem. Phys. 2016, 18, 7251–7260. [CrossRef]
18. Yeo, R.S.; Chin, D.-T. A Hydrogen-Bromine Cell for Energy Storage Applications. J. Electrochem. Soc. 1980, 127, 549–555. [CrossRef]
19. Brewer, L.; Searcy, A.W. Utilization of equilibrium vapor pressure data. J. Chem. Educ. 1949, 26, 548–552. [CrossRef]
20. Fischer, J.; Bingle, J. The Vapor Pressure of Bromine from 24 to 116◦. J. Am. Chem. Soc. 1955, 77, 6511–6512. [CrossRef]
21. Ramsay, W.; Young, S. XLV.—On the vapour-pressures of bromine and iodine, and on iodine monochloride. J. Chem. Soc., Trans.
1886, 49, 453–462. [CrossRef]
22. Barna, G.G. Oxidation of H[sub 2] at Gas Diffusion Electrodes in H[sub 2]SO[sub 4] and HBr. J. Electrochem. Soc. 1982, 129, 2464.
[CrossRef]
23. Barna, G.G.; Frank, S.N.; Teherani, T.H.; Weedon, L.D. Lifetime Studies in H[sub 2]/Br[sub 2] Fuel Cells. J. Electrochem. Soc. 1984,
131, 1973. [CrossRef]
24. Cho, K.T.; Tucker, M.C.; Ding, M.; Ridgway, P.; Battaglia, V.S.; Srinivasan, V.; Weber, A.Z. Cyclic Performance Analysis of
Hydrogen/Bromine Flow Batteries for Grid-Scale Energy Storage. ChemPlusChem 2015, 80, 402–411. [CrossRef]
25. Saadi, K.; Nanikashvili, P.; Tatus-Portnoy, Z.; Hardisty, S.; Shokhen, V.; Zysler, M.; Zitoun, D. Crossover-tolerant coated platinum
catalysts in hydrogen/bromine redox flow battery. J. Power Sources 2019, 422, 84–91. [CrossRef]
26. Kosek, J.A.; Laconti, A.B. Advanced hydrogen electrode for a hydrogen-bromine battery. J. Power Sources 1988, 22, 293–300.
[CrossRef]
27. Schneider, M.; Rajarathnam, G.P.; Easton, M.E.; Masters, A.F.; Maschmeyer, T.; Vassallo, A.M. The influence of novel bromine
sequestration agents on zinc/bromine flow battery performance. RSC Adv. 2016, 6, 110548–110556. [CrossRef]
28. Bryans, D.; Berlouis, L.; Spicer, M.; McMillan, B.G.; Wark, A. Synthesis and Characterisation of Novel Additives for Use in the
Hybrid ZnBr 2 Flow Battery. ECS Trans. 2017, 77, 33–36. [CrossRef]
29. Rajarathnam, G.P.; Easton, M.E.; Schneider, M.; Masters, A.F.; Maschmeyer, T.; Vassallo, A.M. The influence of ionic liquid
additives on zinc half-cell electrochemical performance in zinc/bromine flow batteries. RSC Adv. 2016, 6, 27788–27797. [CrossRef]
30. Bryans, D.; McMillan, B.G.; Spicer, M.; Wark, A.; Berlouis, L. Complexing Additives to Reduce the Immiscible Phase Formed in
the Hybrid ZnBr 2 Flow Battery. J. Electrochem. Soc. 2017, 164, A3342–A3348. [CrossRef]
31. Lancry, E.; Magnes, B.-Z.; Ben-David, I.; Freiberg, M. New Bromine Complexing Agents for Bromide Based Batteries. ECS Trans.
2013, 53, 107–115. [CrossRef]
Molecules 2021, 26, 2721 25 of 26
32. Cathro, K.J.; Cedzynska, K.; Constable, D.C. Some properties of zinc/bromine battery electrolytes. J. Power Sources 1985, 16, 53–63.
[CrossRef]
33. Hoobin, P.M.; Cathro, K.J.; Niere, J.O. Stability of zinc/bromine battery electrolytes. J. Appl. Electrochem. 1989, 19, 943–945.
[CrossRef]
34. Magnes, B.Z.; David, I.B.; Lancry, E.; Bergstein-Freiberg, M. Additives for Zinc-Bromine Membraneless Flow Cells. U.S. Patent
9,722,272, 1 August 2017.
35. Linden, D.; Reddy, T.B. Handbook of Batteries, 3rd ed.; McGraw-Hill: New York, NY, USA, 2002; ISBN 0-07-135978-8.
36. Eustace, D.J. Bromine Complexation in Zinc-Bromine Circulating Batteries. J. Electrochem. Soc. 1980, 127, 528–532. [CrossRef]
37. Singh, P.; Jonshagen, B. Zinc-bromine battery for energy storage. J. Power Sources 1991, 35, 405–410. [CrossRef]
38. Kautek, W. In Situ Investigations of Bromine-Storing Complex Formation in a Zinc-Flow Battery at Gold Electrodes. J. Electrochem.
Soc. 1999, 146, 3211–3216. [CrossRef]
39. Jeon, J.-D.; Yang, H.S.; Shim, J.; Kim, H.S.; Yang, J.H. Dual function of quaternary ammonium in Zn/Br redox flow battery:
Capturing the bromine and lowering the charge transfer resistance. Electrochim. Acta 2014, 127, 397–402. [CrossRef]
40. Skyllas-Kazacos, M.; Kazacos, G.; Poon, G.; Verseema, H. Recent advances with UNSW vanadium-based redox flow batteries. Int.
J. Energy Res. 2010, 34, 182–189. [CrossRef]
41. Poon, G.; Parasuraman, A.; Lim, T.M.; Skyllas-Kazacos, M. Evaluation of N-ethyl-N-methyl-morpholinium bromide and N-ethyl-
N-methyl-pyrrolidinium bromide as bromine complexing agents in vanadium bromide redox flow batteries. Electrochim. Acta
2013, 107, 388–396. [CrossRef]
42. Cathro, K.J.; Cedzynska, K.; Constable, D.C.; Hoobin, P.M. Selection of quaternary ammonium bromides for use in zinc/bromine
cells. J. Power Sources 1986, 18, 349–370. [CrossRef]
43. Kautek, W.; Conradi, A.; Fabjan, C.; Bauer, G. In situ FTIR spectroscopy of the Zn–Br battery bromine storage complex at glassy
carbon electrodes. Electrochim. Acta 2001, 47, 815–823. [CrossRef]
44. Saadi, K.; Kuettinger, M.; Fischer, P.; Zitoun, D. Hydrogen-Bromine Redox-Flow Battery Cycling with Bromine Complexing
Agent: On the Benefits of Nanoporous Separator Versus Proton Exchange Membrane. Energy Technol. 2021, 9, 2000978. [CrossRef]
45. Aupoix, A.; Pégot, B.; Vo-Thanh, G. Synthesis of imidazolium and pyridinium-based ionic liquids and application of 1-alkyl-3-
methylimidazolium salts as pre-catalysts for the benzoin condensation using solvent-free and microwave activation. Tetrahedron
2010, 66, 1352–1356. [CrossRef]
46. Bonhôte, P.; Dias, A.-P.; Papageorgiou, N.; Kalyanasundaram, K.; Grätzel, M. Hydrophobic, Highly Conductive Ambient-
Temperature Molten Salts †. Inorg. Chem. 1996, 35, 1168–1178. [CrossRef]
47. Deyko, A.; Hessey, S.G.; Licence, P.; Chernikova, E.A.; Krasovskiy, V.G.; Kustov, L.M.; Jones, R.G. The enthalpies of vaporisation
of ionic liquids: New measurements and predictions. PCCP 2012, 14, 3181–3193. [CrossRef]
48. Butkene, R.V.; Mikul’skene, G.V.; Mikher-Lorka, O.S.; Kupyatis, G.-K.K. Alkylation of 4-picolinium salts under phase transfer
conditions. Chem. Heterocycl Compd. 1989, 25, 433–438. [CrossRef]
49. Ghosh, R.; Ekka, D.; Rajbanshi, B.; Yasmin, A.; Roy, M.N. Synthesis, characterization of 1-butyl-4-methylpyridinium lauryl sulfate
and its inclusion phenomenon with β-cyclodextrin for enhanced applications. Colloids Surf., A 2018, 548, 206–217. [CrossRef]
50. Shimizu, Y.; Wachi, Y.; Fujii, K.; Imanari, M.; Nishikawa, K. NMR Study on Ion Dynamics and Phase Behavior of a Piperidinium-
Based Room-Temperature Ionic Liquid: 1-Butyl-1-methylpiperidinium Bis(fluorosulfonyl)amide. J. Phys. Chem. B 2016, 120,
5710–5719. [CrossRef]
51. Yim, T.; Lee, H.Y.; Kim, H.-J.; Mun, J.; Kim, S.; Oh, S.M.; Kim, Y.G. Synthesis and Properties of Pyrrolidinium and Piperidinium
Bis(trifluoromethanesulfonyl)imide Ionic Liquids with Allyl Substituents. Bull. Korean Chem. Soc. 2007, 28, 1567–1572. [CrossRef]
52. Lungwitz, R.; Spange, S. Determination of hydrogen-bond-accepting and -donating abilities of ionic liquids with halogeno
complex anions by means of 1H NMR spectroscopy. Chemphyschem 2012, 13, 1910–1916. [CrossRef]
53. Hayward, G.C.; Hendra, P.J. The far infra-red and Raman spectra of the trihalide ions IBr−2 and I−3. Spectrochim. Acta Part. A:
Mol. Spectrosc. 1967, 23, 2309–2314. [CrossRef]
54. Evans, J.C.; Lo, G.Y.-S. Vibrational Spectra of the Cl 3 − Ion and Evidence for the Existence of Cl 5−. J. Chem. Phys. 1966, 44,
3638–3639. [CrossRef]
55. Skyllas-Kazacos, M. Novel vanadium chloride/polyhalide redox flow battery. J. Power Sources 2003, 124, 299–302. [CrossRef]
56. Chen, X.; Rickard, M.A.; Hull, J.W.; Zheng, C.; Leugers, A.; Simoncic, P. Raman spectroscopic investigation of tetraethylammonium
polybromides. Inorg. Chem. 2010, 49, 8684–8689. [CrossRef]
57. Burns, G.R.; Renner, R.M. A Raman and resonance Raman study of polybromide anions and a study of the temperature
dependence of the Raman-active phonons of tetrabutylaminonium tribromide. Spectrochim. Acta Part. A Mol. Spectrosc. 1991, 47,
991–999. [CrossRef]
58. Person, W.B.; Anderson, G.R.; Fordemwalt, J.N.; Stammreich, H.; Forneris, R. Infrared and Raman Spectra, Force Constants, and
the Structures of Some Polyhalide Ions: ICl 2−, ICl 4−, BrCl 2−, and Br 3−. J. Chem. Phys. 1961, 35, 908–914. [CrossRef]
59. Kanno, H.; Hiraishi, J. Existence of H3O+ ions in glassy aqueous HX solutions (X = Cl and Br). Chem. Phys. Lett. 1984, 107,
438–441. [CrossRef]
60. Walrafen, G.E. Raman Spectral Studies of Water Structure. J. Chem. Phys. 1964, 40, 3249–3256. [CrossRef]
61. Kanno, H. Raman study of aqueous HX solutions (X = F, Cl, Br and I) in both liquid and glassy states. J. Raman Spectrosc. 1993, 24,
689–693. [CrossRef]
Molecules 2021, 26, 2721 26 of 26
62. Murphy, W.F.; Bernstein, H.J. Raman spectra and an assignment of the vibrational stretching region of water. J. Phys. Chem. 1972,
76, 1147–1152. [CrossRef]
63. Haller, H.; Hog, M.; Scholz, F.; Scherer, H.; Krossing, I.; Riedel, S. [HMIM][Br9]: A Room-temperature Ionic Liquid Based on a
Polybromide Anion. Z. Für Nat. B 2013, 68. [CrossRef]
64. Schrader, B.; Meier, W. Raman/IR Atlas organischer Verbindungen/of Organic Compounds; Verlag Chemie: Weinheim/Bergstr, The
Neatherlands, 1974.
65. Küttinger, M.; Wlodarczyk, J.K.; Daubner, D.; Fischer, P.; Tübke, J. High energy density electrolytes for H 2 /Br 2 redox flow
batteries, their polybromide composition and influence on battery cycling limits. RSC Adv. 2021, 11, 5218–5229. [CrossRef]
66. Hamer, W.J.; DeWane, H.J. Electrolytic Conductance and the Conductances of the Halogen Acids in Water; U. S. Government Printing
Office: Washington, DC, USA, 1970.
67. Kreuer, K.-D.; Rabenau, A.; Weppner, W. Vehikel-Mechanismus, ein neues Modell zur Deutung der Leitfähigkeit schneller
Protonenleiter. Angew. Chem. 1982, 94, 224–225. [CrossRef]
68. Howe, A.T.; Shilton, M.G. Studies of layered uranium(VI) compounds. I. High proton conductivity in polycrystalline hydrogen
uranyl phosphate tetrahydrate. J. Solid State Chem. 1979, 28, 345–361. [CrossRef]
69. Papancea, A.; Patachia, S.; Porzsolt, A. Conductivity studies of imidazolium-based ionic liquids in aqueous solution. Bull. Transilv.
Univ. Bras. 2015, 57, 67–72.
70. Wlodarczyk, J.; Küttinger, M.; Cantu, B.; Fischer, P.; Schumacher, J. An enhanced 1-D model of a hydrogen-bromine flow battery.
In Proceedings of the 16th Symposium on Modeling and Experimental Validation of Electrochemical Energy Technologies
(ModVal 2019), Braunschweig, Germany, 12–13 March 2019; Book of Abstracts; Volume 16, p. 93. [CrossRef]
71. Hamer, W.J.; Wu, Y.-C. Osmotic Coefficients and Mean Activity Coefficients of Uni-univalent Electrolytes in Water at 25 ◦C. J.
Phys. Chem. Ref. Data 1972, 1, 1047–1100. [CrossRef]
72. Sashina, E.S.; Kashirskii, D.A.; Janowska, G.; Zaborski, M. Thermal properties of 1-alkyl-3-methylpyridinium halide-based ionic
liquids. Thermochim. Acta 2013, 568, 185–188. [CrossRef]
73. Dzyuba, S.V.; Bartsch, R.A. Efficient synthesis of 1-alkyl(aralkyl)-3-methyl(ethyl)imidazolium halides: Precursors for room-
temperature ionic liquids. J. Heterocycl. Chem. 2001, 38, 265–268. [CrossRef]
74. Fleischmann, M.; Hendra, P.J.; McQuillan, A.J. Raman spectra of pyridine adsorbed at a silver electrode. Chem. Phys. Lett. 1974,
26, 163–166. [CrossRef]
75. Cook, D. Vibrational spectra of pyridinium salts. Can. J. Chem. 1961, 39, 2009–2024. [CrossRef]
76. Bard, A.J.; Faulkner, L.R. Electrochemical Methods: Fundamentals and Applications, 2nd ed.; John Wiley & Sons, Inc.: New York, NY,
USA, 2001; ISBN 978-0-471-04372.
77. Vielstich, W. Theorie und Anwendung der rotierenden Scheibenelektrode. Z. Anal. Chem. 1960, 173, 84–87. [CrossRef]
78. Treimer, S.; Tang, A.; Johnson, D.C. A Consideration of the Application of Koutecký-Levich Plots in the Diagnoses of Charge-
Transfer Mechanisms at Rotated Disk Electrodes. Electroanalysis 2002, 14, 165. [CrossRef]
79. Frumkin, A.; Nekrasov, L.; Levich, B.; Ivanov, J. Die Anwendung der rotierenden Scheibenelektrode mit einem Ringe zur
Untersuchung von Zwischenprodukten elektrochemischer Reaktionen. J. Electroanal. Chem. (1959) 1959, 1, 84–90. [CrossRef]
80. Haller, H.; Schröder, J.; Riedel, S. Structural evidence for undecabromide [Br11]-. Angew. Chem. Int. Ed. 2013, 52, 4937–4940.
[CrossRef]
81. Easton, M.E.; Ward, A.J.; Hudson, T.; Turner, P.; Masters, A.F.; Maschmeyer, T. The formation of high-order polybromides in a
room-temperature ionic liquid: From monoanions ([Br5 ](-) to [Br11 ](-) ) to the isolation of [PC16 H36 ]2 [Br24 ] as determined by
van der Waals Bonding Radii. Chem. Eur. J. 2015, 21, 2961–2965. [CrossRef]
82. Evans, J.C.; Lo, G.Y. Vibrational spectra of BrO−, BrO2−, Br3−, and Br5−. Inorg. Chem. 1967, 6, 1483–1486. [CrossRef]
83. Bauer, G.; Drobits, J.; Fabjan, C.; Mikosch, H.; Schuster, P. Raman spectroscopic study of the bromine storing complex phase in a
zinc-flow battery. J. Electroanal. Chem. 1997, 427, 123–128. [CrossRef]
84. Haynes, W.M.; Lide, D.R. (Eds.) CRC Handbook of Chemistry and Physics: A Ready-Reference Book of Chemical and Physical Data,
2015–2016, 96th ed.; CRC Press: Boca Raton, FL, USA, 2015; ISBN 978-1482260960.
85. Küttinger, M.; Brunetaud, R.; Wlodarczyk, J.K.; Fischer, P.; Tübke, J. Cycle behaviour of hydrogen bromine redox flow battery
cells with bromine complexing agents. J. Power Sources 2021, 495, 123–128. [CrossRef]
